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General Abstract 
It has been suggested that moderate exercise contributes to protection against the 
development of chronic diseases by anti-inflammatory mechanisms that include 
elevations of anti-inflammatory cytokines and also reduction of the expression of Toll-
Like Receptors (TLRs). However, prolonged strenuous exercise has been shown to 
reduce the function of some immune cells, decrease virus protection and consequently 
may account for the reason athletes appear more vulnerable to catching Upper 
Respiratory Tract Infections (URTI). Although it has been proven that some exercise is 
better than no exercise, it is not clear yet what is the right amount of exercise to elicit 
beneficial immune responses and to help prevent the development of diseases. 
Therefore, the general aim of the studies in this thesis was to evaluate the impact of 
different types of exercise on monocyte TLR expression in participants with different 
fitness levels. It was found that different acute exercise protocols elicit different 
changes in TLR2 and TLR4 expression, where an acute bout of strenuous exercise 
reduced TLR4 expression for a few hours after the completion of the exercise (Chapter 
5); however, short two bouts of exhaustive exercise separated by 2 hours did not change 
TLR4 expression (Chapter 6). In addition, changes in TLR4 expression were related to 
sex and the physical activity level of the participants (Chapter 4), and should therefore 
be considered separately when analysing TLR4 expression. Furthermore, high-intensity 
intermittent training improves participants’ aerobic capacity and modifies the monocyte 
subpopulation concentration in the blood, with no changes in TLR4 expression. Further 
research needs to be done in this area to achieve a conclusive finding about changes in 
TLR4 expression and monocyte subsets after different training protocols, and possible 
relationships to cytokine production.  
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1. Introduction 
It is well established that exercise contributes to the protection against the development 
of chronic diseases such as cardiovascular disease (CVD) and diabetes (Hardman and 
Stensel 2009, Gleeson et al. 2011c). Explanations for this phenomena include the fact 
that exercise helps to reduce visceral fat mass, increases anti-inflammatory cytokine and 
myokine production (cytokines produced by contractile muscle), and reduces the 
expression of Toll-Like Receptors (TLRs on monocytes) (Flynn and McFarlin 2006, 
Gleeson et al. 2011c). Moreover, increased fitness results in an augmented basic 
functional capacity, which consequently results in a longer and better quality of life. 
The increased interest in physical exercise regimens as a means of preventing the 
development of chronic disease can be something beneficial not only for the individual 
but also for the economy. In the UK, around £30.7 billion per year are spent on the 
treatment and care of people with CVD (British Heart Foundation 2008). However, 
although it might be suggested that a cardiac rehabilitation programme through physical 
exercise would cost less money annually than treating the disease with medication or 
surgery, no cost estimate for such an exercise regimen has yet been reported. Besides, 
prevention is better than cure. 
Exercise has been shown to induce elevations of anti-inflammatory cytokines such as 
Interleukin (IL)-10 (Gleeson et al. 2011c), and also to reduce the expression of TLRs 
(Flynn et al. 2003). It has therefore been suggested that reduction in the TLR expression 
and consequent reduction in cytokine release should be the next step forward in 
research for the decrease of CVDs (McFarlin et al. 2006). To date, few studies have 
been done in this area. Flynn et al. (2003) observed that 10 weeks of resistance training 
reduced CD14+ monocyte TLR4 expression in elderly women and, from this group, the 
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low TLR4 “expressers” had lower cytokine production compared with the high TLR4 
“expressers”. In addition, McFarlin et al. (2004) showed that monocyte TLR4 
expression was lower in resistance-trained women and was associated with lower pro-
inflammatory cytokines, and that physical activity status (but not age) influenced both 
TLR4 expression and IL-6 production (McFarlin et al. 2006). 
However, several studies have also shown that prolonged strenuous exercise reduces the 
function and expression of some immune cells such as monocytes, neutrophils, T 
lymphocytes and natural killer cells, suggesting that strenuous exercise may reduce the 
hosts capacity to act against invading pathogens (Bermon 2007, Gleeson and Bishop 
2005, Nieman 1995). This could represent an ‘open window’ for pathogens, allowing 
upper respiratory tract infection (URTI) and other common infections to gain a foot-
hold (Nieman 1994). The changes of several inflammatory markers – including TLR 
expression – in this context can decrease protection against virus and may consequently 
account for why athletes appear to be more vulnerable to catching URTI. In response to 
the needs of athletes and coaches, the prevention of illnesses during training and 
competition is highly coveted by sport scientists, since infection almost inevitably 
negatively affects performance (West et al. 2009). Although factors such as previous 
URTI episodes and environmental aspects may have influenced the prevalence of 
infections, more research is required to determine the causes of immune system 
function diminution and its positive and negative impacts on human health. 
In 1994, a “J”-shaped curve was proposed by Nieman, which described the relationship 
between exercise load and susceptibility to infections, where, on one hand, regular 
moderate physical activity reduces the risk of URTI below the sedentary individual’s 
risk. On the other hand, performing a high exercise training load is associated with an 
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above average risk of URTI. But although it is seems that there is a common knowledge 
that a moderate amount of exercise is better than no exercise, and that too much 
exercise with little rest can be detrimental to health, there is not a definite consensus in 
the literature on the right amount of exercise that would elicit increased well-being 
response, whilst helping to prevent the development of disease without compromising 
the immune system. It is important also for the athletic population to know how much 
daily exercise can be done in order to improve performance, whilst also avoiding URTI. 
Therefore, the general aim of the studies in this thesis was to evaluate the impact of 
different types of exercise on monocyte TLR expression on participants with different 
levels of fitness. Since TLR is a relatively new immunological ‘marker’ used in the 
exercise field, it was hoped that this studies would provide some insights on how 
exercise elicits a positive or negative response on monocyte TLR and some other 
immunological markers. The main purposes of the present research studies were to: 
1) Investigate the reproducibility of blood measurements, the validity of the 
methods and coefficient of variation of the flow cytometry analysis. 
2) Determine the resting values of monocyte TLR4 expression in sedentary and 
active people. In addition, analyse the effect of sex and physical activity level on 
monocyte TLR4 expression. 
3) Investigate the influence of prolonged cycling exercise at 75% VO2peak on 
monocyte TLR2 and TLR4 expression in healthy men.  
4) Investigate the influence of repeated high-intensity exercise (two VO2peak tests) 
separated by 2 hours on monocyte TLR4 expression in healthy men. 
17 
 
5) Examine the effects of 2 and 4-weeks of high-intensity interval training on the 
monocyte subpopulations, TLR4 expression and plasma IL-6 in sedentary and in 
obese individuals. 
It was hypothesised that: 
- TLR4 expressions would be different according to training status. 
- A single bout of high-intensity exercise would reduce TLR2 and TLR4 
expression for several hours after exercise. 
- An exercise training regimen would reduce TLR4 expression in a sedentary 
population of both normal and high body mass index (BMI) participants. 
An overview of the nine Chapters included in this thesis is given as follows: 
Chapter 1: Provides a general introduction to the research developed.  
Chapter 2: Contains the main literature review relevant for the studies described in the 
thesis. 
Chapter 3: Details the general materials and methods used in the experimental part of 
the studies. Any specific methodology is described in the subsequent relevant Chapters. 
This Chapter also presents the methods and results of reproducibility tests of blood 
measurements and the coefficient of variation of the flow cytometry and cell count 
analysis. 
Chapter 4: Presents results from the first study. This Chapter focuses mainly on training 
and sex differences in TLR4 expression and its possible relationship with respiratory 
infection incidence. 
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Chapter 5: Presents results from the second study. It describes the influence of 
prolonged cycling exercise at 75% VO2peak on monocyte TLR2 and TLR4 expression in 
healthy men. 
Chapter 6: Presents results of the third study, developed due to results obtained in the 
previous Chapters. This study investigates the monocyte CD14+ TLR4 responses after 
two VO2peak tests separated by 2 hours. 
Chapter 7: Presents results from the fourth study. This Chapter analyses the effects of 
two weeks of high-intensity training on monocyte TLR2 and TLR4 expression in high 
BMI sedentary men. 
Chapter 8: Provides results of the fifth study, developed due to results obtained in the 
previous Chapter. This study investigates the effects of a 4-week period of high-
intensity intermittent training (HIIT) on monocyte TLR4 expression in low activity 
level participants. 
Chapter 9: Contains a general discussion, conclusions and the limitations of the 
research conducted. It also suggests further research questions and potential areas for 
future study. 
  
19 
 
2. Literature Review 
2.1.  Role of the Immune System 
The immune system recognises, controls, regulates and generates memory against 
infection. When a foreign body reaches the human body, an immediate response is 
generated by the innate immune system, which is the organism’s first line of defence. 
Innate immunity is instantly available to battle a wide range of pathogens but it is not 
specific and does not lead to long-lasting immunity. Innate immunity can be separated 
into three main mechanisms that prevent the entry of foreign agents into the body: (1) 
the physical barriers such as skin and mucosa; (2) chemical barriers such as enzymes 
and low pH in the gut and (3) phagocytic white blood cells (Gleeson 2006, Murphy et 
al. 2008).  
Monocytes, macrophages, neutrophils and dendritic cells are the major phagocytic cells 
of the immune system and have as their main function the capacity to engulf and ingest 
foreign material. In addition, neutrophils and monocytes can migrate from the 
circulation into tissues if the tissue is damaged or infected.  
When an infection is recurrent or the innate immune system fails to resist the micro-
organism, the adaptive immune system is activated to act against the pathogen. The 
adaptive immune system consists of T- and B-lymphocytes and it is developed during 
the lifetime of an individual as an adaptation to infection with specific pathogens, 
creating an immunological memory (Murphy et al. 2008). 
Although the immune system is comprised of two different divisions, they act 
cooperatively to combat pathogens. Some phagocytic cells from the innate immune 
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system form a link to the adaptive immune system by acting as antigen presenting cells 
(APCs). In short, after the phagocytic cell ingests and processes the foreign body, they 
release cytokines and also present parts of the pathogen’s protein molecules to different 
cells of the adaptive immune system. This process leads to the initiation of specific 
responses. When the connection is made with B-cells, these lymphocytes will multiply 
and differentiate into plasma cells: a cell type that produces antibodies and combats the 
extracellular pathogens. When the link is with T-cells, three different connections can 
be made: (1) connections with T-cytotoxic cells, which are capable of killing infected 
cells; (2) connections with T-helper cells, which send signals to produce and release 
more cytokines, activate B-cells and macrophages and (3) connections with T-
regulatory cells, which control the activity of other immune cells and help to orchestrate 
the immune response. (Gleeson 2006, Murphy et al. 2008). This harmonic cross-
communication and co-ordination between the two branches of the immune system is a 
critical factor in the body’s response to cell damage and infection. 
2.2.  Monocyte Subsets 
Monocytes are one of the main APCs found in the circulatory system and the activation 
of these cells leads to inflammatory responses. Diversity in the expression of proteins 
on the human monocyte cell surface defines different monocyte subsets. According to 
the amount of cluster of differentiation (CD)14 and CD16 receptors on its surface, three 
subpopulations of monocyte can be defined: CD14++CD16- cells (also known as 
classical monocytes); and more mature subpopulations consisted of CD14++CD16+ cells 
and CD14+CD16+ (known as pro-inflammatory monocytes). The classical monocytes 
consist of around 80-90% of the total circulatory monocyte population, while together 
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both pro-inflammatory populations consist of only 10-20% (Rogacev et al. 2010, 
Ziegler-Heitbrock 2007).  
It is known that monocyte maturation results in the formation of macrophages and 
dendritic cells. Randolph et al. (2002) suggested that pro-inflammatory monocytes are 
precursors of dendritic cells while only a small percentage of classical monocytes can 
develop into dendritic cells. In addition, pro-inflammatory monocytes have been shown 
to be prodigious producers of pro-inflammatory cytokines (e.g. IL-1 and tumour 
necrosis factor (TNF)-α) and low producers of IL-10 compared with classical 
monocytes (Ziegler-Heitbrock 2007). Augmented numbers of pro-inflammatory 
monocytes have been observed in several inflammatory conditions such as sepsis and 
some diseases such as atherosclerosis and coronary heart disease (CHD, Rogacev et al. 
2010). By contrast, other studies have revealed no relationship between pro-
inflammatory monocytes and diseases such as diabetes and rheumatoid arthritis 
(Ziegler-Heitbrock 2007).  
Monocyte capability of producing cytokines is highly related to TLR ligation (Ziegler-
Heitbrock 2007). This topic will be discussed in depth in the further sections as it has 
been suggested that pro-inflammatory monocytes have a greater expression of TLR, 
especially TLR2 and TLR4 compared with classical monocytes (Ziegler-Heitbrock 
2007, Timmerman et al. 2008). Therefore, it is sensible to suggest that reduction of 
monocyte TLR expression may reduce the incidence of some diseases that are 
associated with chronic low-grade inflammation.  
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2.3. Toll-Like Receptors 
TLRs are trans-membrane proteins located in APCs such as monocytes, macrophages 
and dendritic cells. They are available to recognise an array of pathogen-associated 
molecular patterns (PAMPs) and activate immune responses via intracellular signalling 
(Akira 2003a, Akira and Hemmi 2003, Parker et al. 2007). Each human TLR, from a 
family of at least 10, has specific ligands and functions, as shown in Table 2.1. In 
addition to the recognition role, TLRs are associated with the increased release of 
cytokines and the stimulation of antimicrobial activity by both the innate and acquired 
immune system.  
The discovery of TLRs changed the scientific community’s views on the human body’s 
discrimination between self and non-self. However, it is worth mentioning that the 
innate immune system also has some other means to recognise and interact with 
microbial pathogens, such as the use of complement proteins, NOD proteins and cell 
surface receptors on natural killer cells (Hoebe et al. 2004). Nevertheless, the activation 
of TLRs results in the effective production of pro-inflammatory cytokines such as IL-1, 
IL-6, IL-8 and TNF-α and also results in the activation of the adaptive immune system 
by the presentation of pathogen particles to T cells (Gleeson et al. 2006, Medzhitov 
1997), which will be discussed later. These multiple immune responses are proven to be 
a rapid and efficient way for the human body to deal with infection. However, 
augmented production of inflammatory cytokines is related to the incidence of diseases; 
but little is known of the reasons for this. Explanations have included TLR gene 
mutation due to ageing or simply TLR failure to regulate cytokine production (Gleeson 
et al. 2006, Hoebe et al. 2004). 
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Table 2.1 - TLR location and ligands 
 Location Examples of ligands Reference 
TLR1/TLR2 
TLR2/TLR6 
Cell surface Peptidoglycan; lipoproteins, 
Zymozan 
Akira 2003a, Murphy et al. 2008 
TLR3 Intracellular Double-stranded RNA Brown et al. 2010 
TLR4 Cell surface LPS, RSV Akira 2003, Monick et al. 2003 
TLR5 Cell surface Flagelin Brown et al. 2010, Testro and Visvanathan 
2009 
TLR7 & TLR8 Intracellular Single-stranded RNA Murphy et al. 2008, Brown et al. 2010 
TLR9 Intracellular CpG DNA, hemozoin Brown et al. 2010, Murphy et al. 2008, 
Testro and Visvanathan 2009 
TLR10/TLR2 Cell surface Microbes and fungi Guan et al. 2010, Parker et al. 2007 
 
2.3.1. TLR2 and TLR4 Pathways 
TLR2 and TLR4 are located on the cell surface of APCs and their activation stimulates 
a range of intracellular signalling pathways that coordinate the extent, form and 
duration of the inflammatory response. They are trans-membrane receptors that possess 
an external ligand-binding domain consisting of leucine-rich repeats (LRR) and a 
cytoplasmic region containing a toll/IL-1r domain (TIR), which is essential to activate 
the downstream response in the TLR pathway. TLR2, when connected with its 
heterodimers TLR1, TLR6 and TLR101, recognises lipoproteins directly via the LRR 
region: a capability that TLR4 lacks.  
The gram-negative bacteria that have lipopolysaccharide (LPS) on their surface are 
firstly recognised in the body by the LPS-binding protein, a specific lipid transfer 
protein that delivers LPS to the CD14 receptor present on the surface of phagocytic 
cells. This interaction is followed by the presentation of the LPS by CD14 to the TLR4 
and the link between TLR4 and the protein MD-2 (Akira 2003a, Figure 2.1a). After 
                                                 
1
 TLR10 has been recently discovered and has been associated to TLR1 and TLR2, recognising microbes 
and fungi; however more research in the area is required to confirm these findings (Brown et al. 2010). 
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that, the interaction of the intercellular TIR domain with either TIRAP (TIR-domain-
containing adaptor protein) and myeloid differentiation factor 88 (MyD88) or TRAM 
(TRIF-related adaptor molecule) and TRIF (TIR-domain-containing adaptor inducing 
IFNs) is the next step in this downstream response (Akira 2003a, Akira et al. 2003, 
Akira and Takeda 2004).  
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Figure 2.1- TLR pathways 
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MyD88 interacts with IL-1r-associated kinase (IRAK)-4 which activates other members 
of the IRAK family. This process results in the activation of TRAF6 (tumour-necrosis-
factor-receptor-associated-factor-6) and the activation of transforming-growth-factor-β-
activated kinase 1 (TAK1) and the TAK1-binding protein (TAB1), followed by TAB2 
and 3. The activation of this signalling triggers both MAPK (mitogen-activated protein 
kinases) and nuclear factor-κB (NF-κB) signalling pathways. The activation of the 
inhibitor of nuclear factor-κB kinase (IKK) complex mediates the phosphorylation of 
IκB-α, which is degraded and stimulates the NF-κB to move to the nucleus and initiate 
the transcription of inflammatory cytokines and interferon gamma (IFN-γ) (Akira and 
Hemmi 2003, Brown et al. 2010). Similarly, the MAPK pathway activates kinases that 
stimulate cytokine gene expression inside the cell nucleus and subsequent cytokine 
synthesis (Figure 2.1b).  
Most of TLRs, including TLR2, use the TIRAP + MyD88 route to activate the 
production of IFN-γ, a cytokine responsible for controlling bacterial and viral infection. 
TLR4, however, can also start a pathway through the link with TRAM, following the 
activation with TRIF, which can either associate with TRAF6 or TRAF3. Next, the 
TRAF3 pathway is used and a link is established with TBK1 (TANK-binding kinase 1) 
and IKKi (a TRIF–TBK1 combination) to phosphorylate interferon-regulatory factor 3 
(IRF3), resulting in the production of IFN-β (which is involved in the innate immune 
response activation) and the anti-inflammatory cytokine IL-10 (Brown et al. 2010) 
(Figure 2.1c). It is important to note that the specificity of each TLR with the different 
adaptor will influence the type, magnitude and duration of the inflammatory response. 
For example, the TLR4/MyD88 signalling pathway is used to induce the expression of 
pro-inflammatory cytokines, while TLR2/MyD88 stimulates the production of Th2 cells 
(Brown et al. 2010). 
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Bacteria that are phagocytosed by APCs are degraded to peptide fragments and 
presented to T cells (T helper cells – Th) through the major histocompatibility complex 
(MHC) class II. When Th cells are activated, they differentiate into Th1 or Th2, and 
stimulate the production of cytokines (Gleeson et al. 2006). The Th cells help to 
activate an immune response that includes inflammation and leukocyte infiltration due 
to the recruitment of phagocytes to the affected area (Murphy et al. 2008).  
The final product of TLR activation on APCs such as monocytes is therefore the 
secretion of cytokines (e.g. IL-1, IL-6, IL-12, TNF-α) which leads to subsequent 
immune responses. A similar pathway is followed by other TLRs against bacterial and 
viral infections, fungal infections, and infections with parasites. Thus, TLRs have been 
shown to have an important role not only in the innate immune system process but also 
in the enrolment of adaptive immunity. 
2.3.2. Cytokines 
Cytokines are protein molecules synthesised under different stimuli by some immune 
cells such as monocytes, macrophages, dendritic cells and lymphocytes. They regulate 
cellular function through cell survival, apoptosis, proliferation and differentiation 
(Fulop et al. 2006). They can be classified as pro-inflammatory (e.g. IFN-γ, IL-1, IL-6) 
or anti-inflammatory cytokines (e.g. IL-2, IL-4, IL-5, IL-10). With factors such as 
ageing or obesity, a reduction in the anti-inflammatory cytokine (e.g. IL-2) production 
can occur. Moreover, an increase in the pro-inflammatory cytokine production (e.g. 
TNF-α, IFN-γ, IL-6) can also occur, which can create an unbalanced immune system, 
and may therefore contribute to the occurrence of autoimmune disorders and of chronic 
inflammation processes, leading to the development of metabolic and cardiovascular 
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diseases, including Type II diabetes and atherosclerosis (Fischer et al. 2007, Fulop et al. 
2006).  
IL-6 is a cytokine that can be considered to be both pro- and anti-inflammatory. It is 
produced by monocytes, macrophages and by contracting skeletal muscle (Petersen and 
Pedersen 2006, Pedersen 2009). IL-6 production can negatively affect TNF-α 
production, while activating IL-10 synthesis. Conversely, high circulating IL-6 levels 
are associated with (and are a predictor of risk for) low-grade chronic inflammation and 
the prevalence of numerous diseases. TNF-α is a pro-inflammatory cytokine as its 
function is to induce inflammation. Together with IL-6, TNF-α has been linked to 
several human diseases caused by low-grade chronic inflammation. IL-10 is an anti-
inflammatory cytokine produced by monocytes and Th2 cells that inhibits pro-
inflammatory cytokine synthesis and stimulates antibody production.  
2.3.3. Methods of TLR Analysis and Variability in TLR  
Since TLRs were discovered an increasing number of studies have been conducted in 
the area utilising different methods for analysing TLR expression. Reverse transcription 
polymerase chain reaction (RT-PCR) (Zanchi et al. 2010), western blot (Frisard et al. 
2010) and flow cytometry (Booth et al. 2010, Coen et al. 2010, Simpson et al. 2009, 
Timmerman et al. 2008) are currently the most common methods in current use. In 
addition, both human subjects and mice have been used in exercise-related studies. The 
use of mice has been very common in the analysis of TLR responses in different organs 
(such as lungs) and different APCs (such as dendritic cells), as they can be use for in 
vivo analysis and can also be sacrificed for a thorough analysis of the various immune 
system components. However, due to its specificity and applicability it is more reliable 
to use human participants for sport-related research concerned with human responses, 
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although in humans, only monocyte APCs can be analysed through blood sampling. 
Other important APCs such as macrophages can only be analysed from muscle or 
adipose tissue biopsies (Francaux 2009, Frisard et al. 2010). 
The flow cytometer is a user-friendly instrument capable of quickly distinguishing the 
size and complexity of cells, as well as differentiating cells according to their 
phenotype. Cells can be easily staining with specific antibodies and a selective analysis 
can be done using an user friendly computer program. In addition, before acquiring the 
data, the electronics of the instrument can be optimised for the particular samples 
studied, increasing the reliability of the data.  
2.4. Exercise and the Immune System 
2.4.1. Exercise and Infection Risk 
Several studies have shown that prolonged exercise reduces the function and expression 
of some immune cells such as lymphocytes and natural killer cells, supporting the 
suggestion that strenuous exercise may reduce the host capacity to act against invading 
pathogens (Bermon 2007, Gleeson and Bishop 2005, Brines et al. 1996, Lancaster et al. 
2005, Moreira et al. 2009, Nieman 1995). This could represent an ‘open window’ for 
pathogens, allowing URTI and other common infections to gain a foot-hold (Nieman 
1994). The changes of several inflammatory markers in this context can decrease virus 
protection and consequently may possibly account for why athletes appear to be more 
vulnerable to catching URTI. Moreira et al. (2009) showed in a systematic review that 
in the majority of the studies analysed athletes demonstrated a greater rate of URTI 
when compared with non athletes, and that the risk of infection increases as the training 
load increases.  
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A “J”-shaped curve has been proposed by Nieman in 1994, which describes the 
relationship between exercise load and susceptibility to infections, where, on one hand, 
regular moderate physical activity reduces the risk of URTI below the sedentary 
individual’s risk. On the other hand, performing a high exercise training load is 
associated with an above average risk of URTI (Figure 2.2).  
 
Figure 2.2- J-shaped curve (Adapted from Nieman 1994) 
In addition, it has been seen that intense exercise decreases the expression of TLR 
(Lancaster et al. 2005), which may lead to a less powerful cell-mediated immune 
response and inflammation, due to a diminished monocyte/macrophage and Th-1 cell 
cytokine production. The prevention of illnesses during training and competition is 
highly sought after by sport scientists in response to the urging of athletes and their 
coaches, since infection almost inevitably negatively affects performance (West et al. 
2009). Although factors such as previous URTI episodes and environmental aspects 
(such as pollutants in the road and chlorine in the water) can influence the results found 
so far, more research is required to determine what causes the diminution of the 
31 
 
immune system function, and to what degree this reduction has positive or negative 
effects on human health. 
2.4.2. Exercise and the Prevention of Diseases 
Factors such as poor diet, obesity (especially visceral fat accumulation), age and low 
levels of physical activity or fitness have been suggested to be linked to the increased 
incidence of CVDs such as atherosclerosis, coronary heart disease (narrowing of the 
coronary arteries), and stroke, as well as diabetes and cancer (Hardman and Stensel 
2009). In addition, poor diet (i.e. ingestion of too much energy, fat and sugary foods) 
has been linked to the increased prevalence of obese people especially in Western 
society, which can subsequently lead to the development of hypertension, diabetes and 
hypercholesterolaemia (Hardman and Stensel 2009). In 2002, the World Health 
Organization (WHO) produced a report showing that more than 60% of the world’s 
population is sedentary, and that if they do exercise, people are not often sufficiently 
active to gain any health benefits from it. In the UK physical activity levels are below 
the European average, although the numbers of adults meeting the recommended levels 
of physical activity increased between 1997 and 2006 in England. Inactivity has been 
fairly recently identified as a major risk factor for CHD, where 20% of CHD in 
developed countries is due to low (often zero) levels of physical activity. This statement 
is also true in relation to stroke, where 10% of stroke incidents in developed countries 
were due to sedentarism (World Health Organization 2002).  
One of the possible explanations regarding the relationship between risk factors and the 
development of CHD and other forms of CVD include chronically high levels of 
inflammatory markers in the body. Nicklas et al. (2005) suggested that risk factors are 
linked with low-grade chronic inflammation, which has been shown to be related to 
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complications such as atherosclerosis, oxidative stress and endothelial dysfunction – 
precursors of adverse health conditions. In addition, some studies have shown that 
persistent high levels of circulatory inflammation markers such as C-reactive protein 
(CRP), TNF-α and IL-6 are risk factors for CVD not only in the elderly but also in the 
middle-aged population (Rost et al. 2001, Cesari et al. 2003).  
Myers et al. (2004) showed that low levels of physical fitness and all-cause mortality 
risk are strongly related. According to this study, sedentary people have a greater risk of 
dying prematurely compared with physically active people. The mechanisms by which 
exercise reduces the incidence of CVD are not yet fully understood; however, 
suggestions are being made that exercise may influence lipids and lipoprotein 
metabolism, reduce high blood pressure, improve myocardial perfusion and oxygen 
delivery to the heart and reduce inflammation (Nicklas et al. 2005). Therefore, an 
increasing number of studies are now suggesting a strong association between CVD, 
CHD and inflammation. 
In support of this idea, evidence from observational studies suggests that both 
decreasing body weight and increasing physical activity levels are effective as treatment 
for reducing overall inflammation. For example, Colbert et al. (2004) examined 3,075 
well-functioning, elderly men and women of mixed ethnicity in relation to exercise 
level and the association with circulating levels of CRP, IL-6 and TNF-α. As a result, it 
was found that high levels of physical exercise are related to low levels of all variables 
analysed when compared with non-physically active people. In relation to body fat 
mass, fat location and markers of chronic inflammation, Festa et al. (2001) analysed a 
large multi-ethnic population in relation to body fat mass and fat distribution with 
circulating CRP levels. A strong correlation was found between plasma CRP 
concentration and BMI, waist circumference and adipose body mass, suggesting that 
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inflammatory markers are elevated in populations with a higher adipose mass. It is 
known that adipose tissue releases cytokines due to the reversible infiltration of 
inflammatory cells into the adipose tissue; therefore, weight loss either through diet or 
exercise may reduce inflammation to some extent (Nicklas et al. 2005). 
Moreover, increased fitness results in an augmented basic functional capacity, which 
consequently results in a better and longer quality of life. Therefore, the increased 
interest in physical exercise regimens as a means of preventing the development of 
chronic disease can be something beneficial not only for the individual but also for the 
economy. In the UK, around £30.7 billion per year are spent on the treatment and care 
of people with CVD. However, although it might be suggested that a cardiac 
rehabilitation programme through physical exercise would cost less money annually 
than treating the disease with medication or surgery, no cost estimate for such an 
exercise regimen has been reported as yet (British Heart Foundation 2008). 
In addition, a dysfunctional immune system is also found in the elderly population 
which may be linked with memory loss and degeneration of neurones in older people 
(Fulop et al. 2006). Several studies suggest that the continuous exposure to pro-
inflammatory cytokines could be responsible for the amplified pro-inflammatory status 
related to the malfunctioning and unbalancing of the immune system in both elderly and 
obese populations (Petersen and Pedersen 2005). Nevertheless, exercise has been shown 
to reduce this chronic low-grade inflammation. For example, Stewart et al. (2005) 
showed a reduction in inflammation markers in young and old participants after 12 
weeks of resistance training by assessing circulating levels of IL-1β, IL-6 and TNF- α. 
In support of this research, a cross sectional study by McFarlin et al. (2006) showed that 
a physically active lifestyle may possess anti-inflammatory properties regardless of sex 
or age. Therefore, exercise-induced elevations of anti-inflammatory cytokines such as 
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IL-10, combined with training-induced lowering the expression of APC receptors such 
as toll-like receptor (TLRs) could play an important role in the link between exercise 
and reduced inflammation (Flynn et al. 2003; Gleeson 2007, Gleeson et al. 2011c). 
Reduction in the TLR expression and consequent reduction in cytokine release has 
therefore, been suggested to be the next step forward in research for the decrease of 
CVDs. Few studies in this area have been done so far. Flynn et al. (2003) observed that 
10 weeks of resistance training reduced CD14+ monocyte TLR4 expression in elderly 
women and, from this group, the low TLR4 “expressers” had lower cytokine production 
compared with the high TLR4 “expressers”. In addition, McFarlin et al. (2004) showed 
that monocyte TLR4 expression was lower in resistance trained women and was 
associated with lower inflammatory cytokines. Subsequent research showed that 
physical activity status (but not age) influenced both TLR4 expression and IL-6 
production (McFarlin et al. 2006). 
2.5. Exercise and TLR Response 
2.5.1. Acute Strenuous Exercise and TLR2 and TLR4 Responses 
Several studies have indicated that different types of physical activity may play a role in 
modifying TLR expression and downstream responses (Flynn et al. 2003, McFarlin et 
al. 2004, McFarlin et al. 2006, Stewart et al. 2005). Furthermore, it has been suggested 
that a large number of immune system aspects, including TLR expression and function 
can be influenced by strenuous exercise (Lancaster et al. 2005), but results have not 
always been consistent. TLR2 and TLR4 expression have been shown to be reduced 
after an acute bout of strenuous cycling exercise (Lancaster et al. 2005) but other 
studies reported no change in TLR2 after 45 minutes of running (Simpson et al. 2009) 
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and even an increase in both TLR2 and TLR4 expression after cycling a 60-km time 
trial (Booth et al. 2010). From the decline in TLR function reported by Lancaster et al. 
(2005) and Simpson et al. (2009), it was suggested that reductions in accessory signal 
molecule expression (e.g. Human Leukocyte Antigen DR-1, HLA.DR), costimulatory 
molecule expression (e.g. CD80 and CD86) and APC activation after acute exercise 
may occur, which may impair immune function and increase susceptibility to infection 
such as URTI (Gleeson 2006). Other factors that also may be related to the reduction in 
cell surface expression of TLR2 and TLR4 after an acute bout of strenuous exercise are 
the heat shock proteins (HSPs), the changes in HLA.DR expression and the circulating 
concentration of cytokines such as IL-6 and IL-10 (Gleeson et al. 2006, Simpson et al. 
2009). The inconsistent results may be due to the difference in participant fitness levels, 
exercise type, duration and intensity and methods used to analyse the variables; 
therefore, care must be taken to interpret these results. 
2.5.2. Chronic Exercise and TLR2 and TLR4 Responses 
There have been several studies (both cross-sectional and longitudinal) showing that 
people who engage in regular moderate-intensity physical activity maintain a lower risk 
of self reported respiratory symptoms than both the sedentary and athletic population 
(Martin et al. 2009, Matthews et al. 2002, Nieman 1997, Nieman et al. 2010). In 
addition, it has been suggested that TLR2 and TLR4 responses can be modified with 
physical training such as endurance and resistance exercises (Stewart et al. 2005). Two 
studies suggested that exercise-induced changes in monocyte TLR2 and TLR4 may be 
cumulative over time since 12 weeks of resistance and aerobic exercise training has 
been shown to reduce messenger RNA (mRNA) for TLR4 and cell surface TLR4 
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expression (Flynn et al. 2003, Stewart et al. 2005), although research to confirm these 
findings is limited to date.  
Increased levels of monocyte TLR expression have shown to be linked with higher 
cytokine production possibly leading to chronic inflammation (Stewart et al. 2005, 
Timmerman et al. 2008, Vitseva et al. 2008). As mentioned previously, chronic 
inflammation is related to the development and progress of several diseases (Parker et 
al. 2007); therefore the reduction in TLR2 and TLR4 expression in sedentary 
populations through exercise may be a crucial key in reducing the severity, or even 
preventing, the occurrence of chronic diseases. 
2.5.3. The Influence of Sex and Training levels on TLR2 and TLR4 Expression 
To date, only two studies have compared the TLR4 expression between a young and old 
population. According to Stewart et al. (2005), TLR4 expression was reduced equally 
after 12 weeks of exercise in both young (18-35 year olds) and old (65-85 year olds) 
subject groups. Similarly, McFarlin et al. (2006) showed that TLR4 expression is 
related to physical activity status but not age. Although the authors used both male and 
female participants, there are no studies as yet comparing the TLR2 and TLR4 
expression between sexes.  
A study conducted by Gleeson et al. (2011a) examined sex differences in several 
immunological markers and URTI incidence. Higher salivary flow rates, and higher 
immunoglobulin A (IgA, an antibody related to mucosal immunity) concentration and 
secretion rates were observed in males compared with females who engaged in a similar 
volume (average 10h/week) of endurance-based exercise training. Although this study 
showed no sex difference in the number URTI episodes, leukocyte counts, and antigen-
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stimulated cytokine production by whole blood culture, monocyte TLR expression was 
not analysed, suggesting the need for research in this area. 
2.6. Overview 
This Chapter presents a review of the role of the immune system, with a focus on 
monocyte subsets, TLR and cytokines. It has been suggested that monocyte capability 
in producing cytokines is highly related to TLR stimulation and that pro-inflammatory 
monocytes have a greater expression of TLR2 and TLR4 compared with classical 
monocytes. The activation of TLRs results in rapid multiple immune responses such as 
cytokine production, proven to be a competent way for the human body to deal with 
infection. On the contrary, augmented production of inflammatory cytokines is related 
to the incidence of chronic diseases that may have been caused by TLR gene mutation 
or failure to regulate cytokine production.  
This Chapter also describes how physical exercise has been related to positive 
(prevention of chronic diseases) and negative (increased susceptibility to URTI) effects 
on the immune system, and how this may be related to the influence of exercise on 
TLR2 and TLR4 expression, resulting in subsequent changes in cytokine production. 
Moreover, it draws attention to the available research that has investigated factors such 
as the amount, intensity, duration and type of exercise, and their influence on TLR 
responses, leading either to a positive or a negative outcome. Little research has been 
done to analyse the influence of sex on TLR2 and TLR4 expression for an active 
population and its influence on the immune system. This indicates that the TLR 
response to exercise requires more attention and, in conjunction with that, the responses 
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of other immunological markers (such as IL-6 and IL-10) and their association with 
TLR expression must also be investigated.  
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3. General Methods 
3.1. Introduction 
This Chapter is separated into five main sections, describing the common material and 
methodology used in the studies. Any other specific methods and participants’ 
characterization is discussed in more detail in the appropriate Chapter. Section 3.2 
describes the recruitment criteria for the selection of participants. The general exercise 
protocols are described in section 3.3. The biochemical assays and any other method 
used for analyses of the participants’ whole blood and plasma are described in section 
3.4. Section 3.5 outlines the statistical analysis and section 3.6 presents the methods and 
results of reproducibility tests of blood measurements and the coefficient of variation of 
the flow cytometry and cell count analyses.  
3.2. Recruitment Criteria for the Selection of Participants 
The recruitment criteria varied according to each study and it will be described in detail 
in the respective Chapters. As a common criterion, before voluntarily giving their 
informed consent, participants were fully informed (verbally and in writing) of the 
nature of the experimental procedures and possible risks of the experiments. All 
participants were asked to complete a general health screening and a physical activity 
questionnaire in which they described their weekly training levels (see Appendices). 
The health screen questionnaire was checked to ensure that they were suitable to 
participate. In addition, they were made aware of their right to withdraw from the study 
at any time without justification. Participants then signed an informed consent form. 
Ethical approval for all studies was obtained from Loughborough University ethics 
committee and studies were conducted in accordance with the Declaration of Helsinki. 
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The main criteria for the direct exclusion of participants from the studies were:  
- Having any of their family members, otherwise healthy, under the age of 35 that 
died suddenly during or soon after exercise; 
- Smoking; 
- Problems with joints, muscles or tendons that would compromise their 
performance in exercise studies; 
- Any illness or diseases that could influence the immunological results (including 
cold or flu in the previous 4 weeks prior to the study); 
- Those having donated more than 500 ml of blood in the three months preceding 
the study; 
- Taking medications known to influence (directly or indirectly) leukocyte 
function or inflammation, 
- Having a VO2peak result above or below the range specified for the study. 
3.3. Exercise Protocol 
No exercise was conducted in one study described in this thesis (Chapter 4). In this 
study, participants were asked to maintain their regular daily activity and physical 
activity routines, but to refrain from physical activity the day before attending the 
laboratory. The monitoring and recording of their physical activity levels was 
undertaken using an international physical activity questionnaire (IPAQ, 
http://www.ipaq.ki.se/downloads.htm) providing quantitative information on training 
loads in metabolic equivalent (MET)-h/week (Craig et al. 2003). In Chapter 5, all 
participants completed three exercise bouts: two preliminary trials (VO2peak 
determination and Familiarisation) and one main trial. In Chapter 6 participants 
performed one VO2peak test, then two VO2peak tests separate by two hours in the 
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following week. Chapter 7 describes a 2-week training study which required two 
preliminary exercise bouts (VO2peak determination and Familiarisation) and one main 
trial, followed then by 2 weeks of exercise training and then the repetition of the main 
trial and VO2peak determination. Chapter 8 had the same preliminary exercises as 
Chapter 7, followed then by 4 weeks of exercise training and then the repetition of the 
VO2peak determination and main trial. All main trials were only performed if participants 
had avoided strenuous physical activity the day before coming to the laboratory. 
3.3.1. VO2peak Determination  
Participants completed a continuous incremental exercise test to volitional exhaustion 
on a cycle ergometer. Different protocols were used in different studies. 
 
- For Chapters 5 and 6 participants cycled on a Monark 874E ergometer. After a 
short warm-up (no more than 5 min with a load of no more than 60 W), 
participants began cycling at 95 W. The work rate was increased by 35 W every 
3 min, until volitional exhaustion. A Douglas bag was used to collect the 
expired gas during the final minute of each stage. Also at this time, rating of 
perceived exertion (RPE, using the 6 – 20 Borg Scale) and heart rate (using a 
Polar A1 telemetric device, Polar Electro, Kempele, Finland) were recorded. 
When the participant signalled that they could continue for only 1 more minute 
at the required intensity, a new expired gas collection was commenced and 
verbal encouragement was given, and the test was ended after the minute was 
complete. Expired gas was analysed by a Servomex O2 and CO2 analyser (series 
1400, Crowborough, UK), and the gas volume was measured using a dry gas 
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meter (Harvard Instruments, Edenbridge, UK), allowing determination of the 
VO2 at each work rate.  
- For Chapter 7 an Excalibur electrically braked cycle ergometer (Lode Excalibur, 
Groningen, The Netherlands) was used. After a short warm-up (no more than 5 
min with the load no more than 60 W), participants began cycling at 100 W and 
had the work rate increased by 30 W every 3 min with participants cycling at 70 
rpm. The work rate was increased by 35 W every 3 min, until volitional 
exhaustion. An online breath by breath analyser (Ultima CPX, MedGraphics, 
MN, USA) was used to measure expired gas. Heart rate and RPE (Polar RS200, 
Polar Electro, Kempele, Finland) were recorded every 3 minutes.  
- For Chapter 8, an Excalibur electrically braked cycle ergometer (Lode 
Excalibur, Groningen, The Netherlands) was used following the same protocol 
described above. When female participants were recruited, the work load started 
at 75 W and was increased by 25 W every 3 min. 
 
In order to confirm that subjects performed at their maximum effort, all test results were 
checked to see if at least two out of the three following criteria were met: subjects 
achieved within 10 bpm of their age predicted maximum heart rate (where maximum 
heart rate = 220 beats.min-1- participant’s age); participants’ respiratory exchange ratio 
(RER) was >1.15 or they indicated a score of ≥ 19 on the RPE scale (Whaley et al. 
2005). 
3.3.2. High-Intensity Intermittent Training – HIIT 
The high-intensity intermittent training protocol was used in Chapters 7 and 8. In this, 
participants performed ten 4-min cycling intervals each separated by a 2-min rest period 
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at a workload corresponding to that which elicited 90% of their VO2peak. Heart rate and 
RPE measurements were made during the last 30 s of each 4-min stage. 
3.4. Blood Sample Collection, Plasma Separation and Biochemical Assays  
3.4.1.  Blood Sample Collection and Plasma Separation 
Samples of whole blood were collected in 4 ml vacuum tubes containing EDTA and in 
6 ml vacuum tubes containing sodium heparin as anticoagulant (Becton-Dickinson, 
Oxford, UK). Whole blood was collected from the antecubital vein by venepuncture. 
Blood EDTA samples were used to measure the total blood count using an automated 
haematology analyser (AC·T 5diff, Beckman Coulter, Buckinghamshire, UK) and then 
centrifuged for 10 min at 1500 g at 4ºC (Allegra 21R, Beckman Coulter, 
Buckinghamshire, UK). Aliquots of plasma were immediately stored within a -80 °C 
freezer for future analysis. Any changes in plasma volume before and after exercise 
trials were calculated from measurements of haemoglobin and haematocrit according to 
the method described by Dill and Costill (1974). Heparinised blood samples were used 
to determine the cell surface expression of TLR on circulating monocytes (described in 
section 3.4.2). 
3.4.2.  CD14+ Monocyte and TLR Expression  
In order to determine the cell surface expression of TLR on circulating CD14+ 
monocytes 80 µl of heparinized blood was surface stained with monoclonal antibodies 
containing different fluorochromes: 20 µl CD14-Fluorescein isothiocyanate (FITC) 
(Becton– Dickinson Bioscience, Oxford, UK) and antihuman phycoerythrin (PE)-
conjugated TLR2 (clone TL2.1, 20 µl), PE-TLR4 (clone HTA125, 20 µl) or PE-Isotype 
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control (Mouse IgG2k, 20 µl) (e-Bioscience, San Diego, CA). All the tubes were 
incubated at room temperature for 20 min in darkness. To lyse the red blood cells, tubes 
were then filled with a lysis buffer solution (10x dilution, FACS lyse, BD Biosciences, 
Oxford, UK) and re-incubated for 10 min under the same conditions. All samples were 
then centrifuged at 1000 g for 6 min (Allegra 21R centrifuge, Beckman Coulter, 
Buckinghamshire, UK). Supernatants were aspirated and cell pellets were re-suspended 
in phosphate buffered saline (PBS) containing 0.1% of bovine serum albumin (BSA) 
and 2 mM EDTA and centrifuged as previously described. Finally, supernatants were 
aspirated again, and cell pellets were re-suspended in 500 µl of PBS/BSA/EDTA buffer 
and transferred to FACS tubes for analysis.  
Samples were analysed on a flow cytometer (BD FACSCalibur) equipped with the 
CellQuest software package (BD Biosciences, Oxford, UK). The FACSCalibur flow 
cytometer is equipped with a blue laser that emits light at a wavelength of 488 nm. The 
light emitted by this laser is directed at cells as they pass through in single file flow. 
The diffracted, refracted and reflected light emitted from the cells is then passed 
through various filters and sensed by optical filters. The detected light signals are then 
transformed into comparative electronic signals and digitised (as dots) on the computer 
screen.  
Before acquiring the data, the electronics of the instrument were optimised for the 
particular samples studied. Instrument compensation adjustments for overlap in the 
emission spectra of the fluorochromes was performed to make sure that each detector 
was only identifying one fluorochrome and that only the cell populations of interest 
came into view on the data plots. To ensure that the instrument settings were stable and 
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to allow consistent conditions over the course of the studies, FACS comp (the in-built 
quality control software) was performed before optimising any instrument settings. 
Cells were gated according to side scatter and CD14-FITC expression (which 
characterises monocytes, Figure 3.1a), and the geometric mean fluorescence intensity 
(GMFI) of the Isotype control (ISO), and of TLR2 and TLR4 antibodies in the CD14+ 
cell gated population was obtained to quantify TLR expression (Figure Figure 3.1b, 
total of 3,000 cells acquired for each sample). Isotype control GMFI was used to correct 
values for non-specific binding. Chapters 7 and 8 present slight differences in this 
protocol (such as the analysis of the monocyte subsets), which will be described in the 
appropriated Chapters. 
 
Figure 3.1- Flow cytometer results exemplified 
One of the main problems in immunology research is the considerable variability that 
exists within and between people. Therefore, a reproducibility study was carried out to 
ensure that the methods applied using the flow cytometer were valid and reliable for 
each individual and for the group, as no study covering that has been shown yet. 
Moreover, as some of the studies mentioned in this thesis differ from the thesis’ 
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methodology for TLR analysis, it is suggested that the interpretation of the results may 
be taken with caution since direct comparisons between studies may be difficult. 
3.5. Statistical Analysis 
Normality tests were carried out on all data. The following tests were used according to 
normality results and the number of variables: 
- Independent or paired sample t-test for normally distributed data; 
- Mann-Whitney U-test for not normally distributed data; 
- For the repeated not normally distributed sample, Friedman’s ANOVA was 
used; if a statistically significant difference was found, a Mann-Whitney U-test 
(corrected for the time points) was carried out to locate the difference;  
- One-way ANOVA with repeated measures for normally distributed data;  
- Pearson’s Correlation, where 0.0 to 0.3 is a weak correlation, 0.4 to 0.6 is 
medium and 0.7 to 1.0 is high correlation (in both ± direction). 
- The program G*Power 3.1.3 (Faul et al. 2007) was used to determine the 
number of participants needed to achieve a power of between 0.6 and 0.8. All 
studies aimed for an effect size of at least 0.5. 
In order to calculate these statistics, PASW version 18.0 for Windows (SPSS, Inc., 
Chicago, IL, USA) was used. Statistical significance was accepted at P < 0.05. All 
results are presented as mean ± standard deviation (SD). 
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3.6.  The Reproducibility of the Flow Cytometry and Cell Count Analysis 
3.6.1. Participants 
For involvement in this small study participants had to be between 18 and 55 years old 
and non-smokers. Ten males and five females were recruited (35 ± 9 years; 71.3 ± 9.3 
kg; 174 ± 10 cm; BMI 23.7 ± 3.0) when comparing the automated blood count machine 
with the manual white blood cell count and for the TLR4 expression reproducibility 
analysis. For the reproducibility of the results produced by the automated blood 
analyser, blood from 49 subjects were used. All participants were healthy and were not 
taking any medication. 
3.6.2. Experimental Procedures 
Participants were asked to come to the Exercise Immunology Laboratory for one visit 
only. In an overnight fasted state they had their body mass and height measured, and 
gave a venous blood sample. Blood samples were collected as described above in 
Section 3.4. 
Cell Count Analysis 
EDTA blood samples (N=49) were analysed in duplicate for assessment of the 
reproducibility and coefficient of variation (CV) of the total cell count, using an 
automated haematology analyser (AC·T 5diff, Beckman Coulter, Buckinghamshire, 
UK). In addition, smears were created by placing 10 µl of blood onto a slide and then 
staining using the Wright’s staining protocol (N=20). Firstly, the blood smear was 
dipped into 100% methanol and left to dry. Once dried, slides were then dipped into 
Wright’s stain (Sigma-Aldrich, Dorset, UK) for 2 min. Subsequently the slides were 
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washed with deionised water and left to dry. Slides were analysed for total white blood 
cell count using a microscope with a 100x lens. A total of 100 white blood cells were 
counted and differentiated by staining characteristics and morphology and results were 
presented as a percentage. 
CD14+ Monocyte and TLR Expression  
Heparinised blood samples were used to determine the reproducibility and the CV of 
the cell surface expression of TLR on circulating CD14+ monocytes. All samples were 
analysed in duplicate using the staining method explained in Section 3.4. 
3.6.3. The Reproducibility of the Cell Count Analysis – Results  
All variables were normally distributed. A paired sample t-test (P < 0.05) was used to 
compare the results of the white blood cell counts from the automated analyser with the 
manual counting of the stained slides. The duplicate analysis of the blood samples using 
an automated machine is shown in Table 3.1.  
Table 3.1 – Blood haematological analysis  
 Analysis CV 
RBC 4.7 ± 0.04 1% 
HCT (%) 40.4 ± 0.3 1% 
HB (g/dL) 13.3 ± 0.08 1% 
WBC (x109/L) 5.9 ± 0.06 1% 
NEU (x109/L) 3.0 ± 0.04 1% 
LYM (x109/L) 2.2 ± 0.5 2% 
MON (x109/L) 0.5 ± 0.03 6% 
EOS (x109/L) 0.2 ± 0.02 12% 
(RBC = Red blood cells; HCT = Haematocrit; 
HB = Haemoglobin; WBC = white blood cell; 
NEU = neutrophil; LYM = Lymphocyte; MON 
= Monocyte; EUS = Eosinophil); all values 
x109/L of blood 
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There was no difference in the white blood cell count when comparing the automated 
and the manual cell count, as shown in Table 3.2.  
Table 3.2 –White blood cell count method comparison of leukocyte subsets (% of total) 
% Automated analyser Slide analysis Pvalue 
WBC 100 100  
NEU 48 ± 9 52 ± 4 0.050 
LYM 38 ± 8 37 ± 7 0.684 
MON 9 ± 2 7 ± 4 0.073 
EOS 3 ± 2 3 ± 2 0.511 
BAS 0 ± 1 1 ± 1 0.334 
(WBC = white blood cell; NEU = neutrophil; 
LYM = Lymphocyte; MON = Monocyte; EUS = 
Eosinophil; BAS = Basophil); all values x109/L of 
blood; N= 20. 
 
3.6.4.  The Reproducibility of the Flow Cytometry Analysis – Results  
Geometric mean fluorescence intensity (GMFI) was 29.1 ± 3.7 for TLR2 and 19.1 ± 2.0 
for TLR4, with a coefficient of variation of the analysis was 10% and 11% respectively. 
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4. Chapter 4 - Training and Sex Differences in TLR4 Expression: Relationship 
with Respiratory Infection Incidence? 
Abstract: The purpose of this study was to determine whether URTI incidence, CD14+ 
monocyte TLR4 expression and cytokine production differed between subjects who 
practiced regular moderate amounts of exercise (MED, N=39) compared with those 
who engaged in very little exercise (LOW, N=13) or more than 9 hours of endurance-
based training per week (HIGH, N=40). In addition, a second aim was to determine if 
sex differences exist in resting CD14+ monocyte TLR4 expression and cytokine 
production by antigen-stimulated whole blood culture in these populations (N=52 males 
and N=40 females). TLR4 expression was shown to be higher in females compared 
with males (40 ± 23 and 28 ± 11 GMFI respectively) and in the population with a low 
compared with a high level of physical activity (39 ± 26 and 32 ± 17 GMFI 
respectively). No differences were found between sexes for stimulated cytokine 
production and URTI symptoms. Different levels of physical activity did not result in 
difference in pro-inflammatory cytokine production, but a difference in the IL-10 anti-
inflammatory cytokine production was found between the physically active groups, 
despite no difference in URTI incidence and no correlation with TLR4 expression. 
Therefore, sex differences and physical activity levels in immune function need to be 
considered in future mixed-gender studies on exercise when analysing TLR4 
expression. 
4.1. Introduction 
Changes in the immune system have been shown to be modulated by exercise and to be 
dependent on intensity and duration (Gleeson 2007). As suggested by Nieman’s “J-
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shape” relationship theory (Nieman 1994), engaging in chronic moderate activity may 
improve immune function above sedentary levels, while high amounts of high-intensity 
prolonged exercise may weaken immune function and increase susceptibility to URTI. 
Little clinical evidence supports the idea of a real difference in immune function 
between the sedentary and physically active population. However, the fact that athletes 
engaged in high amounts of training present higher upper respiratory tract infection 
symptoms than athletes that exercise less hours is confirmed by several studies (Neiman 
et al. 2010, Gleeson et al. 2011b). However, it has been suggested that, in the true 
resting state, immune function in the sedentary individuals and athletes is generally 
similar (Gleeson, 2007). According to Gleeson (2007), a possible reason why prolonged 
exercise increases susceptibility to infection in athletes is due to the decrease of TLR 
expression, with the consequent reduction of cytokine production by macrophages and 
Th1 cells. This may weaken cell-mediated immunity and increase the chances of 
infection. So far, no studies have examined the TLR expression and its relationship with 
URTI episodes in an athletic population; however, it can be suggested that this 
impairment in the immune system may be concerning for athletes, as it can lead to 
impaired exercise performance and persistent fatigue (Gleeson 2007). 
In addition, other variables such as age, sex and lifestyle habits may affect the capacity 
of the immune system to defend against common infections such as URTI (Gleeson et 
al. 2011a, Gleeson et al. 2011b, Gillum et al. 2011). Although few studies found a sex 
difference in some immunological markers such as IL-1, IL-4 and IL-10, others suggest 
that males and females are equally susceptible to infection at rest, and produce similar 
concentrations of pro- and anti-inflammatory cytokines when challenged (Gillum et al. 
2011). For example, Gleeson et al. (2011a) examined sex differences in several 
immunological markers and URTI incidence in a physically active population. Higher 
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salivary flow rates, and higher saliva immunoglobulin A (IgA, an antibody related to 
mucosal immunity) concentration and secretion rates were observed in males compared 
with females that engaged in a similar volume (average 10h/week) of endurance-based 
exercise training. Although this study showed no sex difference in the number of URTI 
episodes, blood leukocyte counts, and antigen-stimulated cytokine production by whole 
blood culture, monocyte TLR expression were not analysed, suggesting the need for 
research in this area. 
The aim of this study was therefore to examine URTI incidence and its possible 
association with resting values of CD14+ monocyte TLR4 expression and cytokine 
production by antigen-stimulated whole blood culture in an athletic population. In 
particular, it was to be determined whether URTI incidence and any immune variables 
differed between subjects who practiced regular moderate amounts of exercise (defined 
as 3-8 hours of exercise per week) compared with those who engaged in very little 
exercise (0-2 h/week, i.e., essentially sedentary people) or more than 9 hours of 
endurance-based training per week. It was hypothesised that high volume training 
would be associated with a higher incidence of URTI and an impaired pro-
inflammatory cytokine response and/or an elevated anti-inflammatory cytokine 
response to the multi-antigen challenge compared with subjects engaged in lower levels 
of physical activity. 
In addition, a second aim was to determine if sex differences exist in resting CD14+ 
monocyte TLR4 expression and cytokine production by antigen-stimulated whole blood 
culture in these populations. It was hypothesised that the incidence of URTI and the 
production of pro- and anti-inflammatory cytokine response to the multi-antigen 
challenge would be different between sexes. 
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4.2. Methods 
Some of the data for this Chapter were collected as part of a project that led to 
publications such as Gleeson et al. 2011a, Gleeson et al. 2011b. Therefore, most aspects 
of the methodology, such as the participants of the study and the protocol are similar to 
the described in these papers. Tests performed specifically in this study and that were 
not described in Chapter 3 are fully explained.  
4.2.1. Participants 
The physically active population were composed of 46 males and 33 females (18 to 35 
year olds) who practiced at least 3 h/week of endurance based activities. Additionally, 6 
males and 7 females (18 to 45 year olds) were recruited as part of the sedentary group 
(Table 4.1). For data analysis, subjects were allocated to one of three groups according 
to their self-reported hours of weekly training: 0-2 h/week, 3-8 h/week and 9 or more 
h/week, designated as low (LOW), medium (MED) and high (HIGH) volume training 
groups, respectively. All participants were asked to complete a general health screen 
questionnaire and a short version of the IPAQ (see Appendices) where they described 
their weekly training levels.  
Table 4.1 – Participants general characteristics 
 Male (N=52) Female (N=40) 
IPAQ score ((MET)-h/week) 64.3 ± 39.2 54.5 ± 27.6 
Training (h/wk) 8.7 ± 5.2 7.6 ± 4.5 
Age (years) 23 ± 5 22 ± 4 
Height (m) 1.8 ± 0.1 1.7 ± 0.1 
Body mass (kg) 79.5 ± 11.7 62.6 ± 5.8 
BMI (kg/(m)2) 24.2 ± 2.8 22.4 ± 2.5 
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4.2.2. Experimental Procedures 
Participants were asked to come to the Exercise Immunology Laboratory in an 
overnight fasted state. Body mass and height were measured, and a resting venous 
blood sample was taken. 
Blood Sample Collection 
Samples of whole blood were collected from an antecubital vein into tubes containing 
EDTA and sodium heparin as anticoagulant (Becton-Dickinson, Oxford, UK).  
Cell Count Analysis 
EDTA samples were analysed for assessment of the total and differential leukocyte 
count, using an automated haematology analyser (AC·T 5diff, Beckman Coulter, 
Buckinghamshire, UK). 
CD14+ Monocyte and TLR Expression  
Heparinised samples were used to determine the cell surface expression of TLR on 
circulating CD14+ monocytes. All samples were analysed for TLR4 expression using 
the staining method explained in Chapter 3. 
Antigen-Stimulated Cytokine Production  
Stimulated whole blood culture production of cytokines (IFN-γ, TNF-α, IL-1β, IL-2, 
IL-4, IL-6, IL-8 and IL-10) was determined as described in Gleeson et al. (2011a) only 
for the physically active groups. The stimulant was a commercially available multi-
antigen vaccine (Pediacel Vaccine, Sanofi Pasteur, UK) containing diphtheria, tetanus, 
acellular pertussis, poliomyelitis and haemophilus influenzae type b antigens. Briefly, 
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heparinised whole blood was cultured with vaccine (1:4000 dilution) at 37 °C and 5% 
CO2 for 24 h. After centrifugation at 1500 g for 10 min at 4ºC, supernatants were 
collected and stored frozen at -80°C prior to the analysis of cytokine concentrations 
using an Evidence Investigator System using the high sensitivity cytokine biochip array 
EV3513 (Randox, County Antrim, UK). The intra-assay coefficient of variation for all 
measured cytokines was less than 5.0%. 
Questionnaires  
During the 4-month subsequent study period subjects on the physically active groups 
were requested to continue with their normal training programmes whilst completing a 
health (URTI symptoms) questionnaire on a weekly basis. Supplements (vitamins and 
minerals, etc.) were not permitted during this period.  Subjects were not required to 
abstain from medication when they were suffering from illness symptoms but they were 
required to report any unprescribed medications taken and visits to the doctor.  
The illness symptoms listed on the questionnaire were: sore throat, catarrh in the throat, 
runny nose, cough, repetitive sneezing, fever, persistent muscle soreness, joint aches 
and pains, weakness, headache and loss of sleep. The non-numerical ratings of light, 
moderate or severe (L, M or S, respectively) of severity of symptoms were scored as 1, 
2 or 3, respectively to provide a quantitative means of data analysis (Fricker et al., 
2005) and the total symptom score for every subject each week was calculated by 
multiplying the total number of days each symptom was experienced by the numerical 
symptom severity rating. A single URTI episode was defined as a period during which 
the weekly total symptom score was ≥12 and separated by at least one week from 
another week with a total symptom score ≥12. Subjects were also asked to rate the 
impact of illness symptoms on their ability to train (normal training maintained, training 
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reduced or training discontinued; L, M or S, respectively). This score was chosen as to 
achieve it, a subject would have to record at least 3 moderate symptoms lasting for 2 
days or 2 moderate symptoms lasting for at least 3 days in a given week. Subjects were 
also asked to fill in a standard short form International Physical Activity Questionnaire 
(IPAQ) at weekly intervals, thus providing quantitative information on training loads in 
metabolic equivalent (MET)-h/week (Craig et al. 2003). 
Statistical Analysis 
Normality tests were carried out on the data. Independent samples t-test and Mann-
Whitney U test were used to compare any sex difference on TLR4 expression and all 
the other variables. The results of the non-parametric test showed similar results to t-
tests, and so only t-test values (P ≤ 0.05) will be presented in the Results section. One 
way ANOVA (P ≤ 0.05) was used to calculate any difference in the TLR4 expression 
according to the physical activity level. Relationships between variables were examined 
using Pearson’s correlation. 
4.3. Results 
4.3.1. Training Load and URTI Incidence 
Participants were divided into three different groups according to their level of physical 
activity (0 to 2h·week-1[LOW, N=13], 3 to 8 h·week-1 [MED, N=39] or ≥ 9 h·week-
1[HIGH, N=40]). The LOW, MED and HIGH groups participated in moderate-vigorous 
exercise for 1.2 ± 0.9, 6.1 ± 1.3 and 12.6 ± 3.7 h·week-1, respectively (P < 0.001). 
Analysis of the IPAQ questionnaires showed that the weekly training loads were 
substantially higher in the HIGH group compared with the MED and LOW groups, and  
also higher on the MED compared with LOW (Table 4.2). The IPAQ scores in MET-
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h/week correlated significantly with subjects’ self-reported training loads at the start of 
the study (r = 0.6, P < 0.001, n=87). 
Analysis of the URTI symptom questionnaires could only be performed in the MED 
and HIGH groups. Results indicated that the HIGH and MED groups experienced 2.5 ± 
2.7 and 1.5 ± 2.5 episodes respectively during the 4-month period but they were not 
significantly different (P = 0.142). However, the proportion of subjects who suffered 
one or more episodes of URTI was higher in the HIGH (68%) compared with the MED 
(59%) group. 
In relation to the haematological values, the LOW group presented lower levels of 
haematocrit and high numbers of lymphocytes compared with MED and HIGH groups 
and higher white blood cell and monocyte counts compared with the HIGH group 
(Table 4.2). 
Table 4.2 - Anthropometric and haematological characteristics of the low (LOW), 
medium (MED) and high (HIGH) volume training groups 
 LOW (N=13) MED (N=39) HIGH (N=40) P value 
IPAQ (MET-h/week) 20.1 ± 8.9 51.9 ± 26.5* 78.3 ± 34.5*$ 0.001 
Training (h/week) 1.2 ± 1.0 6.1 ± 1.3 12.6 ± 3.7*$ 0.001 
Age (years) 25 ± 5 23 ± 4 22 ± 8 0.086 
Height 1.7 ± 0.1 1.8 ± 0.1 1.8 ± 0.1 0.741 
Body Mass 75.5 ± 18.3 70.8 ± 10.7 72.6 ± 12.7 0.505 
BMI 24.8 ± 3.9 23.1 ± 2.6 23.4 ± 2.5 0.162 
RBC 4.4 ± 0.8 4.7 ± 0.5 4.7 ± 0.5 0.072 
HCT 37.6 ± 6.6 41.2 ± 3.5* 40.9 ± 3.1* 0.013 
HB 14.5 ± 1.7 13.9 ± 1.3 13.8 ± 1.2 0.239 
WBC 7.0 ± 1.2 6.0 ± 1.5 5.6 ± 1.3* 0.008 
NEU 3.4 ± 0.8 3.1 ± 1.2 2.8 ± 1.0 0.185 
LYM 2.7 ± 0.9 2.1 ± 0.5* 2.0 ± 0.7* 0.006 
MON 0.6 ± 0.2 0.5 ± 0.2 0.5 ± 0.1* 0.046 
EUS 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.804 
* Significant difference from LOW, $ significant difference from MED; Mean ± SD; 
(RBC = Red blood cells; HCT = Haematocrit; HB = Haemoglobin; WBC = white 
blood cell; NEU = neutrophil; LYM = Lymphocyte; MON = Monocyte; EUS = 
Eosinophil); 
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4.3.2. The Resting Values of the Monocyte TRL4 Expression in Different Levels of 
Physical Activity. 
TLR4 expression at rest was higher in the LOW compared with the HIGH group (P = 
0.03), and a trend of a higher TLR4 expression during rest was found for the LOW 
group when compared with the MED group (P = 0.08). Results can be seen in Figure 
4.1. There was no TLR expression difference between the MED and HIGH groups (P = 
1.00) and no difference of TLR4 expression between the sexes within groups (P > 
0.32). 
 
Figure 4.1 – Resting TLR4 expression according to physical activity level.  
* Significantly different from the HIGH group 
4.3.3. Influence of Training Load on Blood Immune Variables 
Analysis of the stimulated whole blood culture production of cytokines could only be 
performed in the MED and HIGH groups. The HIGH group showed higher IL-10 
production after incubation when compared with the MED group. A trend for a 
significant difference was found between MED and HIGH IFN-γ production (P = 
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0.066), where the HIGH group presented a higher cytokine production after incubation 
compared with the MED. No significant differences were found in any of the other 
cytokine analysed (TNF-α, IL-1β, IL-1α, IL-2, IL-4, IL-6 and IL-8, Table 4.3). In 
addition, none of the cytokines were significantly correlated with TLR4 expression (P > 
0.05). 
Table 4.3 – Stimulated whole blood cytokine 
production in medium (MED) and high (HIGH) 
physically active population 
(pg/ml) MED (n=39) HIGH (N=38) P values 
IL-2 production 93.3 ± 177.6 156.55 ± 181 0.127 
IL-4 production 3.7 ± 3.8 4.0 ± 4.6 0.811 
IL-6 production 147.5 ± 127.9 157.3 ± 134.4 0.743 
IL-8 production 1034.8 ± 718.1 1050.1 ± 718.0 0.926 
IL-10 production 2.4 ± 2.1* 5.4 ± 6.6 0.008 
IFN-γ production 15.8 ± 19.0 26.1 ± 28.0 0.066 
TNF-α production 17.3 ± 27.2 28.8 ± 49.0 0.207 
IL-1α production 1.2 ± 1.6 1.4 ± 2.4 0.629 
IL-1β production 8.0 ± 9.7 7.6 ± 6.9 0.850 
* Statistically different from HIGH; IL= 
interleukin; IFN-γ = interferon gamma; TNF-α = 
Tumour necrosis factor 
4.3.4. Sex and URTI Incidence 
Analysis of the URTI symptom questionnaires was performed according to sex. Results 
indicated that the males and females experienced 1.7 ± 2.2 and 2.3 ± 2.5 episodes 
respectively during the 4-month period but this was not significantly different (P = 
0.284). However, the proportion of subjects who suffered one or more episodes of 
URTI was higher in the female (70%) compared with the male (57%) group. 
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4.3.5. Sex Differences in Resting Values of the Monocyte TRL4 Expression 
Participants’ CD14+ monocyte TLR4 expression was analyzed according to sex (Figure 
4.2). Males presented lower TLR4 expression (28 ± 11 GMFI) when compared with 
females (40 ± 23 GMFI) at P = 0.01. 
 
Figure 4.2 – Resting TLR4 expression according to sex.  
* Significant difference compared with males (Female N=33, Male N=46; P < 0.05) 
 
4.3.6. Sex Differences on Anthropometric and Haematological characteristics  
Males were taller (P = 0.001), heavier (P = 0.001) and, therefore, had a slightly higher 
BMI (24 ± 3 and 23 ± 2 kg.m-2 respectively, P = 0.003) compared with females. There 
was no significant difference in the hours exercised per week between the sexes, where 
males exercised 8.7 ± 5.2 h per week and females exercised 7.4 ± 4.5 h per week (P = 
0.213). There was also no difference in age between sexes (P = 0.425).  
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In relation to the haematological values, males presented higher numbers of red blood 
cells, haematocrit and haemoglobin concentration compared with females, as shown in 
Figure 4.3. 
 
Figure 4.3 – Haematological values 
* Significant difference from female group; Mean ± SD; RBC = Red blood cells 
(x1012/L); WBC = white blood cell (x109/L); NEU = neutrophil (x109/L); LYM = 
Lymphocyte (x109/L); MON = Monocyte (x109/L); EOS = Eosinophil (x109/L); 
HCT = Haematocrit (%); HB = Haemoglobin (g/L) 
4.3.7. Influence of Sex on Blood Immune Variables 
Analysis of the stimulated whole blood culture production of cytokines was performed 
in the male and female groups. No significant differences were found in any of the 
cytokines analysed (IFN-γ, TNF-α, IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8 and IL-10, 
Table 4.4), although there was a trend for higher IL-1β and IL-8 cytokine production in 
males. None of the variables were correlated to TLR4 expression within the sexes (all P 
> 0.05). 
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Table 4.4 - Stimulated whole blood cytokine production in males and females 
(pg/ml) Males (n=45) Females (N=33) P values 
IL-2 production 113.8 ± 136.8 135.8 ± 229 0.625 
IL-4 production 3.4 ± 4.1 4.3 ± 7.5 0.514 
IL-6 production 163 ± 132.4 135.9 ± 126.2 0.355 
IL-8 production 1162 ± 739.0 867.5 ± 639.9 0.063 
IL-10 production 3.9 ± 5.4 3.7 ± 4.7 0.840 
IFN-γ production 28.9 ± 58.8 26.1 ± 54.3 0.833 
TNF-α production 27.6 ± 46.8 16.1 ± 25.5 0.169 
IL-1α production 1.5 ± 2.4 1.0 ± 1.2 0.177 
IL-1β production 9.1 ± 10.1 5.9 ± 4.9 0.073 
* Statistically different from HIGH; IL= interleukin; IFN-γ = 
interferon gamma; TNF-α = Tumour necrosis factor 
4.4. Discussion 
The main finding of the present study was that males and females present similar 
aspects of immunity but females have a higher CD14+ monocyte TLR4 expression 
compared with males. However, levels of TLR4 expression were not related to URTI 
incidence, and therefore this difference seems to not be significant enough to 
considerably affect susceptibility to URTI. There were no significant differences in the 
cytokine production by antigen-stimulated whole blood culture in these populations. 
The hypothesis that the incidence of URTI and the production of pro- and anti-
inflammatory cytokine response to the multi-antigen challenge were different between 
sexes was therefore not verified. Males presented higher values for red blood cells, 
haematocrit and haemoglobin compared with females; however all the values were 
within the normal healthy range. Blood leukocyte, neutrophil, monocyte and 
lymphocyte counts were similar in men and women so it is important to emphasise that 
most aspects of immunity measured in this study were not different between the sexes. 
A limitation of the present study is that the phase of the menstrual cycle was not 
determined when the blood sample was taken and it was not established whether or not 
the females were taking oral contraceptives. Immune functions in females are subject to 
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endogenous oestrogenic effects (Gillum et al. 2011), so it is possible that some of the 
female endurance athletes in our study could be amenorrhoic (have lower oestrogen 
levels) due to the high training loads,  making their immune variables more similar to 
that of men. Some studies found however that the menstrual cycle did not affect some 
immunological parameters in trained athletes (Burrows et al. 2002, Gillum et al. 2011). 
Sex differences in immune function among athletes probably do not therefore need to 
be considered in future mixed gender studies on exercise, infection and immune 
function unless TLR4 expression has been analysed. 
In addition, this study examined the URTI incidence and its possible association with 
resting values of CD14+ monocyte TLR4 expression and cytokine production by 
antigen-stimulated whole blood culture in an athletic population. Results showed that 
URTI incidence and most of the immune variables analysed were not different between 
the MED and HIGH activity groups, and did not correlate with TLR4 expression. 
However, the anti-inflammatory cytokine IL-10 production was higher after stimulation 
in the HIGH group compared with the MED. Cytokine production was not analysed in 
the LOW group, which impaired the comparison with the MED and HIGH groups. 
Therefore, only the hypothesis that high volume training would be associated with an 
elevated anti-inflammatory cytokine response compared with subjects engaged in lower 
levels of physical activity was verified. When comparing the three groups according to 
their TLR4 expression the low physical activity group had higher CD14+ monocyte 
TLR4 expression when compared with the HIGH group. Even though there was a 
difference in the number of males and females in each group, it is worth noting that 
there was no difference in TLR4 expression between the sexes within groups. 
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It has been suggested that IL-10 is able to impair the ability of APCs to promote the 
differentiation and proliferation of CD4+ T cells, thereby regulating both initiation and 
perpetuation of adaptive T-cell responses (Murphy et al. 2008). This happens through a 
downregulation of MHC antigens, the intercellular adhesion molecule-1, as well as the 
costimulatory molecules CD80 and CD86 on antigen presenting cells. In addition, IL-
10 has been shown to promote differentiation of dendritic cells expressing low levels of 
MHC class II, CD80, and CD86 (Maynard & Weaver, 2008). That could potentially 
increase the risk of URTI; however, no difference was found between the MED and 
HIGH group, although the HIGH group had 9% more participants reporting URTI 
symptoms compared with the MED.  
As suggested by Lancaster et al. (2005), higher TLR expression on monocytes was 
considered one possible reason for an elevated cytokine production in response to an 
antigen challenge. In addition, it has been seen that lower TLR4 expression can be 
found in trained compared with sedentary subjects in both cross sectional (McFarlin et 
al. 2006) and longitudinal training studies (Stewart et al. 2005). Similar findings were 
obtained in the present study, where low levels of training resulted in higher monocyte 
TLR4 expression. A limitation of the present study is that vaccine stimulated cytokine 
production was not analysed for the LOW group, making the interpretation of the data 
for the LOW group limited. Nevertheless, the production of none of the measured 
cytokines correlated with monocyte TLR4 expression in the MED or HIGH groups. A 
few small differences were found between the groups in relation to the haematological 
values and white blood cell counts. However all the values are within the normal 
healthy range. 
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Thus, TLR4 expression has been shown to be higher in females compared with males 
and in the population with a low compared with a high level of physical activity. No 
differences were found between sexes for stimulated cytokine production and URTI 
symptoms. Different levels of physical activity do not result in difference in pro-
inflammatory cytokine production, but a difference in the IL-10 anti-inflammatory 
cytokine production was found between the physically active groups, despite no 
difference in URTI incidence and no correlation with TLR4 expression. Therefore, sex 
differences and physical activity levels in immune function need to be considered in 
future mixed-gender studies on exercise when analysing TLR4 expression.  
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5. The Influence of Prolonged Cycling Exercise at 75% Vo2peak on Monocyte 
TLR2 and TLR4 Expression in Healthy Men 
Abstract: Several studies have reported that some immune cell functions including 
monocyte TLR expression and antigen presentation are temporarily impaired following 
acute bouts of strenuous exercise, which could represent an ‘open window’ to URTI. 
However, the time course of effects of acute exercise on human monocyte TLR 
expression was not yet known. The purpose of the present study was to examine the 
effects of 1.5 h cycling at 75% VO2peak on human monocyte TLR2 and TLR4 
expression and how long it takes for TLR expression to return to pre-exercise values. 
Nine healthy endurance trained males (age 25 ± 5 years) had blood samples taken 
before and for up to 24 h after exercise and analysed using flow cytometry. Although 
there was an increase in the total monocyte cell count at 0, 1 and 4 h post-exercise (P < 
0.01) compared to pre-exercise values. Monocyte TLR4 expression was reduced 
(geometric mean fluorescence intensity, corrected for non-specific binding; P < 0.05) 
by 32% and 45% at 0 and 1 h post-exercise, respectively, returning to baseline values 
by 4 h post-exercise. No statistically significant changes were found in TLR2 
expression after exercise. In addition, a control resting study was conducted on six 
healthy endurance trained men (age 25 ± 2 years) to analyse any diurnal changes on 
monocyte TLR2 and TLR4 expression but no changes were found across time (P > 
0.05). This study showed that prolonged cycling at 75% VO2peak temporarily reduces 
TLR4 expression, which may, in part, be responsible for post-exercise 
immunodepression. 
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5. .Introduction 
Reduced immune cell functions after prolonged exercise could represent an ‘open 
window’ for pathogens, allowing URTI and other common infections to gain a foot-
hold (Nieman 1994). Several studies have indicated that both chronic exercise training 
(combined resistance and aerobic regimens) and acute bouts of prolonged exercise may 
play a role in modifying TLR4 expression and downstream responses (Flynn et al. 
2003; McFarlin et al. 2004, 2006; Stewart et al. 2005). A study by Lancaster et al. 
(2005) reported that TLR2 and TLR4 expression on CD14+ blood monocytes was 
reduced following 1.5 h of cycling at 65% VO2max in the heat. Simpson et al. (2009) 
showed that TLR4 (but not TLR2) expression on CD14+ blood monocytes was reduced 
after running for 45 min at 75% of VO2max. The reasons why there are changes in TLR 
expression after a single bout of exercise is not yet known. Nevertheless, suggestions 
have been made regarding how the augmented level of heat shock proteins (HSPs) and 
cytokines in the blood might affect the TLR responses, but more research in this area is 
needed (Gleeson et al. 2006). The acute effects of exercise on TLR expression in the 
study by Lancaster et al. (2005) may have been influenced by increases in core 
temperature, yet it is not clear if acute post-exercise depression of TLR expression can 
be mediated by cycling exercise in thermoneutral conditions. Additionally, it is 
presently unknown how long monocyte TLR expression takes to recover after an acute 
bout of prolonged exercise. 
Therefore, the aim of the present study was to determine the influence of 1.5 h of 
cycling exercise at 75% VO2peak in thermoneutral conditions on monocyte CD14+ TLR2 
and TLR4 expression in healthy men and the time course of any changes over the 
following 24 h. It was hypothesised that acute strenuous cycling exercise would 
influence the expression of TLR2 and TLR4 for several hours following exercise. 
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Although numerous studies have reported changes in TLR2 and TLR4 after exercise, no 
study to date has analysed the time course of TLR2 and TLR4 responses beyond 2 h 
post-exercise after a single bout of cycling exercise.  
5.2. Methods 
This Chapter describes the influence of cycling exercise on monocyte TLR2 and TLR4 
expressions in healthy men. A control study was conducted in parallel with the exercise 
study in order to check for any changes in the TLR2 and TLR4 expressions over time 
with subjects in the resting state, with these results also presented in this Chapter. 
Detailed descriptions of the methods are given in Chapter 3. Any methodology that was 
used specially in this study is fully explained in this section, with methods previously 
described are briefly summarised.  
5.2.1. Participants 
Nine healthy endurance trained men (age 25 ± 5 years; body mass 76.8 ± 8.1 kg; 
VO2peak 58.5 ± 5.6 ml·kg-1·min-1, BMI 23.8 ± 1.4 kg·m-2) participated in the exercise 
study. The control resting study was completed by six healthy endurance trained men 
(age 25 ± 2 years; body mass 75.5 ± 5.8 kg; BMI 23.4 ± 0.8 kg·m-2).  
The participants were all non-smokers, were not taking any medication and had 
remained free of symptoms of respiratory infection for at least 4 weeks prior to 
participation in the study. They were asked to abstain from alcohol, caffeine and heavy 
exercise for at least 1 day prior to their visit and the 24 h after the end of the exercise 
trial. The same recommendations and exclusion criteria applied to the resting control 
study. For the exercise study, participants had to achieve a criterion VO2peak minimum 
value of 50 ml·kg-1·min-1.  
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Participants completed a food record diary for the 24-h period before a Familiarisation 
trial and were required to follow the same diet during the 24 h prior to the main trial. 
They also recorded their food intake in the 24 h after the main trial. The food diary was 
used to ensure that subjects avoided intake of caffeine (or caffeine containing foods 
such as chocolate) prior to the exercise trial, since caffeine has been shown to suppress 
some immune responses (Horrigan et al. 2006). 
5.2.2. Experimental Procedures 
All participants completed three exercise bouts: two preliminary trials (VO2peak 
determination and Familiarisation) and one main trial. All trials were separated by at 
least 1 week. 
VO2peak Determination 
Participants were tested as described in Chapter 3. In brief, they completed a continuous 
incremental exercise test to volitional exhaustion on a cycle ergometer (Monark 874E, 
Sweden). When the participant signalled that they could continue for only one more 
minute at the required intensity, a new expired gas collection was commenced and 
verbal encouragement was given, and the test was ended. In order to confirm that 
subjects performed at their maximum effort, all test results were checked to see if at 
least two out of the three criteria were met: subjects achieved within 10 bpm of their 
age predicted maximum heart rate; participants’ RER was >1.15 or they indicated a 
score of >19 on the RPE scale. 
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Familiarisation  
Participants returned to the lab approximately 1 week after the VO2peak test. Two hours 
before arriving in the lab, they consumed their normal breakfast (e.g. either porridge, 
muesli, or toasted bread and orange juice), which averaged (±SD) 1.8 ± 0.3 MJ, 14.8 ± 
0.4 g of protein, 12.2 ± 3.8 g of fat and 69.5 ± 22.6 g of carbohydrate. After eating, 
participants cycled for 1.5 h at the work rate equivalent to 75% of their VO2peak. 200 ml 
of water was consumed every 20 min during exercise. A 60-s sample of expired gas was 
collected using Douglas bags every 10 min during the exercise and measured as 
described previously. Heart rate and RPE measurements were taken every 20 min of 
exercise. The purpose of this Familiarisation trial was threefold: First, to habituate the 
participants to the physical stress of the exercise and to the methods involved in the 
trial; second, to ensure that the participants were able to maintain the selected intensity 
for 1.5 h; and third, to ensure that the selected work rate actually did elicit a relative 
intensity of 75% VO2peak. 
Main Trial 
Participants exercised under similar conditions to those described for the 
Familiarisation trial. They arrived at the laboratory at 09:30, 2 h after having eaten the 
same breakfast as for the Familiarisation ride, for measurement of body mass. After 5 
min seated rest and immediately before beginning to cycle, a resting (PRE) blood 
sample was taken (as described in section 3.4). 
During exercise, expired gas was collected into Douglas bags (60-s sample), after 30, 
60 and 90 min of exercise, for analysis of VO2 and RER. Heart rate and RPE were 
recorded every 20 min during exercise and subjects consumed 200 ml of water every 20 
min during exercise. Body mass was measured again after exercise. Further venous 
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blood samples were taken immediately post-exercise and at 1, 4 and 24 h after exercise. 
All participants remained seated after exercise until after the 1 h post-exercise blood 
sample had been taken. Subsequently, participants were given a standardized lunch 
[consisting of two ham and cheese sandwiches, a sports drink, a piece of fruit (apple or 
banana) and a cereal bar, with a total energy of 2.0 MJ] to eat and were asked to return 
to the laboratory at 4 and 24 h after exercise. Laboratory ambient conditions during the 
trials were 20.7 ± 2.0 °C whit a relative humidity of 48 ± 7%. 
Resting Control Protocol 
All participants in the control study visited the lab after an overnight fast. They arrived 
at the laboratory at 09:20. After a 10 min seated rest, a resting blood sample was taken 
as described in Chapter 3. Participants remained seated for 2.5 h, and further blood 
samples were taken after 1.5 h (equivalent to the post-exercise sample in the exercise 
protocol) and 2.5 h (equivalent to the 1 h post-exercise sample in the exercise protocol).  
5.2.3. Biochemical Analysis 
Blood Analysis  
Haematocrit, haemoglobin, total white blood cell (leukocyte) and monocyte counts 
were determined from the K3EDTA blood at each time point during the main trial 
(PRE, 0, 1, 4 and 24 h post-exercise and the equivalent for PRE, 0 and 1 h post at the 
resting study) using an automated haematology analyser (AC.T 5diV, Beckman 
Coulter, Buckinghamshire, UK). Changes in plasma volume were calculated from 
measurements of haemoglobin and haematocrit according to the method described by 
Dill and Costill (1974). 
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CD14+ Monocyte and TLR Expression 
In order to determine the cell surface expression of TLR on circulating monocytes, 
heparinized blood was surface stained, using the methods described in Chapter 3. In 
short, blood aliquots were stained with CD14- FITC and PE-conjugated TLR2, TLR4 or 
Isotype control. After the treatment previously described, cell pellets were re-suspended 
in 500 µl of PBS/BSA/EDTA buffer and transferred to FACS tubes for analysis. 
Samples were analysed on a flow cytometer (BD FACSCalibur) equipped with the 
CellQuest software package (BD Biosciences, Oxford, UK). Cells were gated according 
to side scatter and CD14-FITC expression (which characterises monocytes; Figure 3.1), 
and the geometric mean fluorescence intensity (GMFI) of the Isotype control (ISO), and 
of TLR2 and TLR4 antibodies in the CD14+ cell gated population was obtained to 
quantify TLR expression (a total of 3,000 cells acquired for each sample). 
5.2.4. Statistical Analysis 
Normality tests were carried out on all data. Total leukocyte count, monocyte count and 
monocyte TLR2 and TLR4 expression results were not normally distributed and 
therefore were analysed using Friedman’s ANOVA (P < 0.05). If a statistically 
significant difference was found, a Wilcoxon signed-rank test (corrected for the time 
points) was carried out to locate the difference (P < 0.01). A paired t test (P < 0.05) 
was used for before and after body mass measurements, as these values were normally 
distributed. One-way ANOVA with repeated measures was used to compare plasma 
volume results with Bonferroni correction if P values were ≤·0.05. In order to calculate 
these statistics, SPSS version 13.0 for Windows (SPSS, Inc., Chicago, IL, USA) was 
used. All results are presented as mean ± SD. 
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5.3. Results 
Mean heart rate, exercise intensity and RPE during exercise are detailed in Table 5.1. 
Table 5.1 - Heart rate, %VO2peak and RPE at 30, 60 and 90 min of exercise. 
 30 min 60 min 90 min 
Heart Rate (bpm) 155 ± 5 158 ± 6 161 ± 9 
%VO2peak 73 ± 5 75 ± 3 76 ± 4 
RPE 14 ± 1 15 ± 2 16 ± 2 
 
Participants lost approximately 0.9 kg of body mass during exercise and plasma volume 
was unchanged immediately post-exercise compared with PRE (P > 0.05). Plasma 
volume was also unchanged at the other timepoints compared with PRE. 
Blood monocyte count was increased immediately after exercise, as well as at 1 h and 4 
h post-exercise (all P < 0.01). Values returned close to resting values after 24 h (P = 
0.375 vs PRE). Similarly, there was an increase in the total leukocyte count at all time 
points up to 4 h post exercise (all P < 0.01), with values returning to normal after 24 h 
(P = 0.367 vs PRE) (Figure 5.1). 
 
Figure 5.1 - Total white blood cell (WBC) and monocyte counts before (PRE) and up 
to 24 h after exercise.  
* Significantly different from PRE (P < 0.01). 
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5.3.1. TLR Expression 
Monocyte cell surface TLR2 expression showed no change across time (X2(4) = 4.178, 
P = 0.402; Figure 5.2a). However, monocyte TLR4 expression was significantly lower 
than PRE at 0 and 1 h post-exercise (X2(4) = 9.511, P < 0.05), which corresponded to a 
32% reduction at 0 h post-exercise and a 45% reduction at 1 h post-exercise compared 
with PRE values. Values had returned to normal at 4 h post-exercise (P = 0.074), as can 
be seen in Figure 5.2b. 
 
Figure 5.2 - (a) CD14+ Monocyte TLR2 and (b) TLR4 expression (GMFI) after 
exercise. 
# Significantly different from PRE (P < 0.05) 
In the resting control study, monocyte cell surface TLR2 and TLR4 expression showed 
no change across time. The GMFI for TLR4 was 26.3 ± 12.5, 22.4 ± 14.1 and 22.4 ± 
16.6 at the 0, 1.5 h and 2.5 h time points, respectively; (X2(2) = 2.333, P = 0.429). The 
GMFI for TLR2 was 32.1 ± 19.6, 29.6 ± 18.5 and 29.8 ± 15.1 at the 0, 1.5 h and 2.5 h 
time points, respectively (X2(2) = 1.334, P = 0.570). 
75 
 
5.4. Discussion 
The present study provides information about changes in the CD14+ monocyte TLR2 
and TLR4 expression after a single bout of 1.5 h of cycling exercise at 75% of VO2peak 
and the time course of recovery. Although there was an increase in the blood monocyte 
count after exercise, TLR4 expression fell by 32% and 45% at 0 and 1 h post-exercise 
but returned to pre-exercise levels within 4 h post-exercise. In contrast, TLR2 
expression showed no statistically significant changes after exercise. Neither TLR2 nor 
TLR4 expression changed over time in the resting control study.  
The findings of the present study corroborate a recent study (Simpson et al. 2009), 
where a reduction in TLR4 expression at 0 and 1.5 h after exercise was found. Simpson 
et al. (2009) analysed the TLR expression on monocyte subpopulations (e.g. 
CD14+/CD16- and CD14+/CD16+) after 15 volunteers ran for 1.5 h at 75% VO2max. 
Interestingly, as in this study, no difference was found in CD14+ monocyte TLR2 
expression after exercise. In addition, the changes in TLR4 expression after exercise 
found in the present study are in accordance with the findings of Lancaster et al. (2005) 
who reported a reduction in TLR4 expression immediately post-exercise and a further 
reduction at 2 h after exercise in a hot environment, independent of changes in 
immunomodulatory hormones such as cortisol. 
In contrast to the present study, Lancaster et al. (2005) observed a reduction in TLR2 
expression after 1.5 h of cycling in the heat. Exercise in the heat is known to be more 
stressful than in thermoneutral conditions (Galloway and Maughan 1997; Walsh and 
Whitham 2006) and it is possible that monocyte TLR2 expression may be affected only 
by a more severe exercise stress stimulus compared with TLR4. 
76 
 
The changes that occurred in the TLR expression in this study are likely to have been 
due to the effects of exercise, as the resting control study on six healthy subjects 
showed that both TLR2 and TLR4 expression did not change when analysed at the 
same time points (equivalent to pre-, post- and1 h post-exercise) as those in the exercise 
study. Furthermore, Lancaster et al. (2005) have previously shown no influence of 
circadian variation in monocyte TLR expression in healthy humans. However, the 
reason why TLR4 expression is reduced after exercise is not fully understood. 
Researchers have suggested a relationship between endogenous ligands (e.g. cytokines, 
necrotic cell products and HSPs) and TLR expression, indicating that both microbial 
and endogenous agents might use the same pathway to activate the adaptive immune 
system (Beg 2002). The changes that occur in TLR expression after exercise may also 
be related to the production and secretion of IL, such as IL-6 and IL-10 (Gleeson et al. 
2006). It is well established that circulating IL-6 levels are elevated after a single bout 
of exercise, and it has been suggested that IL-6 plays an important role in down 
regulating TLR expression in different conditions (Lancaster et al. 2005). Plasma IL-6 
concentration increases after exercise, with little increase in other cytokines such as IL-
1β and TNF-α (Ostrowski et al. 1999; Pedersen and Febbraio 2008). Pedersen and 
Febbraio (2008) have established that intramuscular IL-6 production and IL-6 release 
into the circulation are augmented during prolonged exercise. As TLR activation also 
results in the production of IL-6 through the NF-kB signalling pathway, it is 
hypothesised that high levels of IL-6 in the blood after exercise down regulate the 
expression of TLRs. The decline in TLR expression is associated with reductions in 
accessory signal molecule expression (e.g. CD80 and CD86) and antigen presenting cell 
activation after acute exercise. This may impair immune function and increase 
susceptibility to URTI (Lancaster et al. 2005; Gleeson et al. 2006). 
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Another important endogenous ligand that may influence TLR expression is the HSPs. 
These are proteins presented in all the cells and are up-regulated during physiological 
stress. The HSPs act as chaperones to guide the synthesis, transportation and 
degradation of some proteins (Kilmartin and Reen 2004). In addition, it has been 
suggested that HSPs (e.g. HSP60 and HSP72), in a similar manner to LPS, act as 
activators of TLR4. Kilmartin and Reen (2004) showed that repeated monocyte 
exposure to HSP60 induces a tolerance to HSP and a ‘cross-tolerance’ to LPS 
stimulation, subsequently reducing TLR4 activation. Strenuous exercise results in 
physiological stress due to increased body temperature and muscle damage, so it is 
hypothesised that HSPs in the extracellular environment are increased after exercise and 
could therefore reduce TLR expression. Repeated exposure to HSPs could play a 
critical role in monocyte deactivation and contribute to the increased susceptibility to 
URTI in endurance athletes. 
Nevertheless, the results of the present study showed that monocyte TLR4 expression 
had essentially returned to normal within 4 h following exercise, suggesting that the 
effects of a single bout of exercise in healthy participants is present only for a short 
time. In conclusion, 1.5 h of cycling exercise at 75% VO2peak reduced CD14+ monocyte 
TLR4 expression in healthy men for a few hours, but no changes in TLR2 expression at 
any time point after exercise were found. 
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6. The Monocyte CD14+ TLR4 Responses After Two VO2peak Tests Separated 
by 2 Hours. 
Abstract: Although it has been shown that strenuous bouts of prolonged exercise (45 
min to 1.5 hours) reduce TLR4 expression, it has not yet been found if short duration, 
incremental exercise would elicit similar reduction in TLR4 expression. The aim of this 
study was to analyse the influence of two consecutive VO2peak tests on monocyte TLR4 
expression in healthy men. Nine healthy endurance trained men (age 25 ± 5 years; body 
mass 75.3 ± 8.2 kg; VO2peak 56 ± 3.6 ml kg-1 min-1, mean ± SD) performed two 
incremental VO2peak test until volitional exhaustion separated by 2-h. Venous blood 
samples were taken at rest (PRE) and immediately post-exercise (POST) both tests for 
analysis of haematocrit, haemoglobin, total white blood cell (leukocyte), monocyte 
counts and monocyte CD14+ TLR4 expression. No difference was found for any 
variable analysed at any time point. Thus, two subsequent incremental tests to 
exhaustion did not reduce CD14+ monocyte TLR4 expression, which may suggest that 
the duration or overall load (where overall load = intensity x duration) of the exercise is 
not high enough to induce a depressive immunological response in an active population. 
6.1. Introduction 
The reduction in immune cell function after prolonged strenuous exercise may be 
associated with URTI occurrence (Nieman 1994, Gleeson et al. 2011b). However, the 
mechanism of how exercise affects the immune cell response is not fully understood. 
Suggestions have been made that exercise is linked to the lowering of TLR expression 
and consequently to the lower capacity of the immune system to act against infection. A 
study by Lancaster et al. (2005) reported that TLR2 and TLR4 expression on CD14+ 
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blood monocytes was reduced following a single bout of 1.5 h of cycling at 65% 
VO2max in the heat. In addition Simpson et al. (2009) showed that TLR4 expression on 
CD14+ blood monocytes was reduced after running for 45 min at 75% of VO2max. But 
although it has been shown that strenuous bouts of prolonged exercise (45 min to 1.5 
hours) reduce TLR4 expression, it has not yet been found if short duration, incremental 
exercise would elicit similar reduction in TLR4 expression. Therefore the aim of this 
study was to analyse the influence of two consecutive VO2peak tests on monocyte TLR4 
expression in healthy men. It was hypothesised that a single bout of incremental 
exercise to exhaustion would reduce TLR4 expression, and a further reduction would be 
seen after the second bout of exercise. 
6.2. Methods 
This was a short study which is part of a main study published elsewhere. This Chapter 
describes the influence of two consecutive VO2peak tests on monocyte TLR4 expression 
in healthy men. Detailed descriptions of the methods are given in Chapter 3. Any 
methodology that was used specifically in this study is fully explained in this section, 
whilst the methods previously described are summarised.  
6.2.1. Participants 
Nine healthy endurance trained men (age 25 ± 5 years; body mass 75.3 ± 8.2 kg; 
VO2peak 56 ± 3.6 ml kg-1 min-1) participated in the study. Participants were all non-
smokers, were not taking any medication and had remained free of symptoms of 
respiratory infection for at least 4 weeks prior to participation in the study. They were 
asked to abstain from alcohol, caffeine and heavy exercise for at least 1 day prior to 
their visit.  
80 
 
6.2.2. Experimental Procedures 
All participants completed two exercise bouts: one preliminary trial (VO2peak 
determination) and one main trial. Trials were separated by at least 1 week. 
VO2peak Determination 
Participants were tested as described in Chapter 3. In brief, they completed a continuous 
incremental exercise test to volitional exhaustion on a cycle ergometer (Monark 874E, 
Sweden). The workload started at 95 W and 35 W was added at each 3-min stage. 
When the participant signalled that they could continue for only 1 more minute at the 
required intensity, a new expired gas collection was commenced, verbal encouragement 
was given, and the test was ended. In order to confirm that subjects performed at their 
maximum effort, all test results were checked to see if at least two out of the three 
criteria were met: subjects achieved within 10 bpm of their age predicted maximum 
heart rate; participants’ RER was >1.15 or they indicated a score of >19 on the RPE 
scale. 
Main Trial 
Participants arrived at the laboratory at 09:30, 2 h after having eating breakfast, for 
measurement of body mass. After 5 min seated rest and immediately before beginning 
to cycle, a resting (PRE1) blood sample was taken (as described in section 3.4). 
The main trial consisted of an incremental VO2peak test until volitional exhaustion as 
explained above. No encouragement was given during the test. Venous blood samples 
were taken immediately post-exercise (POST1). All participants remained seated after 
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exercise for 2-h, then a second VO2peak test was performed as described, with a pre 
(PRE2) and a post (POST2) blood taken. 
6.2.3. Biochemical Analysis 
Blood Analysis  
Haematocrit, haemoglobin, total white blood cell (leukocyte) and monocyte counts 
were determined from the K3EDTA blood at each time point during the trial (PRE1, 
POST1, PRE2, POST2) using an automated haematology analyser (AC.T 5diV, 
Beckman Coulter, Buckinghamshire, UK). Changes in plasma volume were calculated 
from measurements of haemoglobin and haematocrit according to the method described 
by Dill and Costill (1974). 
CD14+ Monocyte and TLR Expression 
In order to determine the cell surface expression of TLR on circulating monocytes, 
heparinised blood was surface stained as described in Chapter 3. In short, blood aliquots 
were stained with CD14-FITC and PE-conjugated TLR4 or ISO. After treatment 
previously described, cell pellets were re-suspended in 500 µl of PBS/BSA/EDTA 
buffer and transferred to FACS tubes for analysis. Samples were analysed on a flow 
cytometer (BD FACSCalibur) equipped with the CellQuest software package (BD 
Biosciences, Oxford, UK). Cells were gated according to side scatter and CD14-FITC 
expression (which characterises monocytes), and the geometric mean fluorescence 
intensity (GMFI) of the ISO and TLR4 antibodies in the CD14+ cell gated population 
was obtained to quantify TLR expression (total of 3,000 cells acquired for each 
sample). 
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6.2.4. Statistical Analysis 
Normality tests were performed out on all the data. Total leukocyte count, monocyte 
count and monocyte CD14+ TLR4 expression results were normally distributed and 
were, therefore analysed using repeated measures ANOVA (P ≤ 0.05) with a 
Bonferroni correction. A student t-test was carried out to locate the difference in the 
case P < 0.05. In order to calculate these statistics, PASW version 18.0 for Windows 
(SPSS, Inc., Chicago, IL, USA) was used. All results are presented as mean ± SD. 
6.3. Results 
No changes in plasma volume were found after the tests. In addition, no difference was 
found for CD14+ monocyte TLR4 expression at any time point (P = 0.57, Table 6.1). 
Participants exercised for 23 ± 5 and 22 ± 4 minutes during the first and second tests 
respectively. 
Table 6.1 - TLR4 expression after 2 VO2peak tests separated by 2 hours 
 Rest 1 Post 1 Rest 2 Post 2 
TLR4 expression (GMFI) 37 ± 14 39 ± 14 43 ± 17 38 ± 14 
6.4. Discussion 
The main finding of the present study was that short term intense incremental exercise 
such as VO2peak tests does not influence TLR4 expression in an active male population. 
Therefore, the hypothesis that a single bout of incremental exercise to exhaustion would 
reduce TLR4 expression, and a further reduction would be seen after the second 
exercise bout was not verified. 
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Although Lancaster et al. (2005) and Simpson et al. (2009) found differences in the 
TLR4 expression after an acute bout of exercise, differences in time, intensity and 
duration of the exercise may have contributed to their findings. Although a VO2peak test 
has been considered a strenuous exhaustive activity, the work load performed in the 
first half of the activity may not be high enough to stimulate an immunological response 
in this active population, thus a TLR4 reduction was not seen. Short-period high-
intensity exercise has been shown to improve aerobic capacity and fat oxidation even 
when the total exercise time does not exceed 30 min per session, however no 
immunological markers were analysed in any of these studies (Cornish et al. 2011, 
Gibala et al. 2006, Gibala and McGlee 2008, Serpiello et al. 2011, Talanian et al. 2007). 
Moreover, most of the exercises used in the cited studies consist of high-intensity bouts 
separated by a small recovery, while the present study used a continuous incremental 
load activity with approximately 20 min of duration. 
To conclude, two subsequent incremental tests to exhaustion did not reduce CD14+ 
monocyte TLR4 expression, which may suggest that the duration or overall load (where 
overall load = intensity x duration) of the exercise is not high enough to induce a 
depressive immunological response in an active population. It is recommended that 
further research should be conducted to analyse different types and intensity of exercise 
and the changes in TLR4 responses in active and sedentary populations. 
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7. Effects of Two Weeks of High-intensity Interval Training (HIIT) on 
Monocyte TLR2 and TLR4 Expression in High BMI Sedentary Men 
Abstract: Monocyte TLR expression has been shown to be reduced after a combination 
of aerobic and resistance exercise, but more studies considering the influences of 
different exercise intensities, type and duration on TLR expression are needed. 
Although there is an agreement about the importance of physical exercise, the minimal 
optimal amount needed to improve health status is uncertain. Therefore, the aim of this 
study was to analyse the influence of 2 weeks of high-intensity intermittent exercise 
training on CD14+ monocyte TLR4 expression in a sedentary, high BMI population. As 
a secondary purpose, this study covers the influence of exercise on classical and pro-
inflammatory monocytes and the TLR4 expression before and after a training period in 
these monocyte subsets. Six high-intensity interval training (HIIT) sessions over a 2 
week period (three sessions per week) were completed by 11 participants (24 ± 5 years 
old). Blood samples were taken at the beginning and end of the training period for 
analysis of haematocrit, haemoglobin, total white blood cell (leukocyte), monocyte 
counts, monocyte CD14+ TLR4 expression and monocyte subsets. Two weeks of high-
intensity intermittent exercise training increased VO2peak and total CD14+ monocyte 
TLR4 expression in a sedentary, high BMI population. There was no influence of 
training on the proportions of classical and pro-inflammatory monocyte subsets, but 
TLR4 expression in the majority of these monocyte subsets (apart from CD14++CD16+) 
was higher after the six training sessions. 
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7.1. Introduction  
It has been suggested that chronic elevation of inflammatory biomarkers is related to 
low physical function in the elderly population (Brinkley et al. 2009) and to chronic 
disease conditions such as CVD and diabetes independent of body weight (Fischer et al. 
2007, Nicklas and Brinkley 2009). Interleukin-6, together with C-Reactive Protein 
(CRP), are examples of inflammation biomarkers that have been found to be related to 
the risk of developing chronic metabolic and CVDs, and exercise training has been 
shown to reduce these inflammatory markers (Stewart et al. 2005). Several researchers 
have suggested that exercise-induced reduction of TLR expression and shifts in 
monocyte phenotype could explain the fall in the inflammatory markers measured 
(Coen et al. 2010, Flynn et al. 2003, McFarlin et al. 2006, Stewart et al. 2005, 
Timmerman et al. 2008).  
Stewart et al. (2009) demonstrated that 12 weeks of combined aerobic and resistance 
exercise (3 times per week) significantly increases aerobic capacity and muscle 
strength, and reduces TLR4 expression in both the old and young population with no 
changes in BMI. In addition, stimulated-production of IL-6 was also lower although 
only in the young group. Similar findings were shown by Timmerman et al. (2008), 
where 12 weeks of resistance and aerobic training (3 times per week, around 50 min in 
total) did not change total CD14+ monocyte TLR4 expression but reduced TLR4 
expression in pro-inflammatory monocytes (CD14+CD16+), a monocyte subset reported 
to highly stimulate the production of pro-inflammatory cytokines (Timmerman et al. 
2008). 
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Aerobic, long duration exercise at moderate intensity (around 60% VO2peak) results in 
improved aerobic capacity, increased fat oxidation and increased mitochondrial volume, 
augmenting the capacity to oxidise fat (Chesley et al. 1996, Gibala et al. 2006, Gormley 
et al. 2008). These positive outcomes can be linked to better insulin sensitivity and 
general health (Talanian et al. 2007). Nevertheless, studies have shown that HIIT (high 
power output for a few minutes followed by a resting period) results in similar – if not 
better – augmentation of aerobic capacity and fat oxidation even when total exercise 
time does not exceed 30 min per session (Cornish et al. 2011, Gibala et al. 2006, Gibala 
and McGlee 2008, Serpiello et al. 2011, Talanian et al. 2007). For example, Gibala et 
al. (2006) demonstrated that high-intensity, short duration repeated exercise (4 to 6 
repetitions of 30 s cycling with 4 min recovery) performed 3 times per week for two 
weeks resulted in a similar improvement in performance for a time trial, and increased 
muscle oxidative capacity and muscle buffering to endurance training (90 to 120 min at 
65%VO2peak) in active men. Likewise, Talanian et al. (2007) demonstrated that 10 
repetitions of 4 min at 90% VO2peak followed by 2 min rest increases aerobic capacity, 
power output, fat oxidation and citrate synthase activity in recreationally active women. 
These findings suggest that high-intensity intermittent exercise is a powerful training 
strategy to stimulate adaptations in the skeletal muscle and to improve health in trained 
and untrained individuals (Gibala et al. 2006, Serpiello et al. 2011, Talanian et al. 
2007). 
Monocyte TLR expression has shown to be reduced after a combination of aerobic and 
resistance exercise, but more studies considering the influences of different exercise 
intensities, type and duration on TLR expression are needed. Although there is an 
agreement about the importance of physical exercise, the minimal optimal amount 
needed to improve health status is still uncertain (Gibala and McGlee 2008). In 2002, 
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the World Health Organisation (WHO) produced a report which showed that more than 
60% of the world population is sedentary. In the UK, the physical activity levels are 
below the European average and it is possible that the majority of people might not 
exercise due to time constraints. As HIIT lasting up to one hour has been shown to 
result in greater physiological adaptations than moderate exercise of the same duration, 
it would be beneficial to know if the high-intensity training protocol can also elicit more 
positive immunological changes. Therefore, the aim of this study was to analyse the 
influence of 2 weeks of high-intensity intermittent exercise training on CD14+ 
monocyte TLR4 expression in a sedentary, high BMI population. As a secondary 
purpose, this Chapter covers the influence of exercise on classical and pro-
inflammatory monocytes and the TLR4 expression before and after a training period in 
these monocyte subsets.  
7.2. Methods 
This study was part of a larger study conducted in the School of Sport, Exercise and 
Health Sciences at Loughborough University. Any methodology that was used 
specifically in this study is fully described in this section while the methods previously 
described in Chapter 3 are summarised.  
7.2.1. Participants 
A total of 11 participants aged 24 ± 5 years old were recruited through word of mouth, 
emails and advertisements around the Loughborough University area. Participants were 
all non-smokers, were not taking any medication and had remained free of symptoms of 
respiratory infection for at least 4 weeks prior to participation in the study. This study 
used the same selection methods and exclusion criteria used in Chapter 3 and only 
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sedentary (no more than 2 hours of exercise per week) males were recruited. 
Participants’ anthropometric and fitness characteristics are shown in Table 7.1. 
7.2.2. Experimental Procedures  
VO2peak Determination  
A VO2peak test (as described in Chapter 3) was used to determine participants’ 
maximum aerobic capacity at the beginning and end of the study. 
Main Trial  
Participants arrived in the laboratory at 08:00 after an overnight fast and rested for 5 
min. A blood sample was taken, and this session was repeated 48 h after the end of the 
two-week training period. After this they performed their first training session as 
described below. 
Training Protocol 
Participants completed six training sessions over a 2 week period (three sessions per 
week). Sessions occurred at any time of the day according to the availability of the 
participants. The sessions consisted of participants performing ten, 4-min cycling 
intervals separated by 2-min rest period at a work rate corresponding to that which 
elicited 90% of a participant’s VO2peak. Water was consumed ad libitum during 
exercise. Heart rate and RPE measurements were made at the last 30 s of each 4-min 
stage. The work rate was adjusted (by about 10 W) during training sessions if 
participants reported lower RPE and had a lower heart rate value when compared with 
the values achieved in either the main trial or previous sessions. 
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7.2.3. Biochemical Analysis 
Blood Analysis  
Haematocrit, haemoglobin, total white blood cell (leukocyte) and monocyte counts 
were determined from the K3EDTA blood using an automated haematology analyser. 
Heparinised blood was used to analyse monocyte and TLR expression as described 
below. 
Monocyte Subpopulation Determination and TLR Expression  
For this study a peripheral blood mononuclear cell (PBMC) method was applied before 
staining the cells. 4 ml of Histopaque 1077 (Sigma Aldrich, Dorset, UK) was added into 
a tube and 4 ml of heparinised blood was then carefully layered on top. The tubes were 
centrifuged at 400 g for 30 min at 25ºC. PBMC layer was then aspirated and transferred 
to another tube containing Hank’s buffered salt solution (HBSS, 1:1 dilution) and 
centrifuged at 300 g for 10 minutes at 25ºC. After that the supernatant was aspirated 
and cell pellets were re-suspended in phosphate buffered saline (PBS) containing 0.1% 
of bovine serum albumin (BSA) and 2 mM EDTA.  
In addition to the TLR2 and TLR4 expression on classical CD14+ monocytes, this study 
also analysed the CD16+ monocyte subsets (also called pro-inflammatory monocytes) 
response after exercise. For this, the monoclonal antibody CD16 was included in the 
staining process. Cell staining procedures were similar to those described for the other 
studies in Chapter 3. In brief, 0.5 µl of PBMC were surface stained with 20 µl CD14-
FITC, 20 µl of CD16-PE-Cy5, and antihuman PE-conjugated TLR2 (20 µl), PE-TLR4 
(20 µl) or PE-Isotype control (20 µl). All the tubes were incubated at room temperature 
for 20 min in the dark. In order to lyse the remaining red blood cells, tubes were then 
filled with a lysis buffer solution and re-incubated for 10 min in the same conditions. 
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All samples were then centrifuged at 1000 g for 6 min. Supernatants were aspirated and 
cell pellets were re-suspended in 500 µl of PBS/BSA/EDTA and transferred to FACS 
tubes for analysis. Samples were analysed on a flow cytometer equipped with the 
CellQuest software package. Cells were gated according to side scatter and CD14-FITC 
expression (which characterises monocytes), and the geometric mean fluorescence 
intensity (GMFI) of the Isotype control (ISO), and of TLR2 and TLR4 antibodies in the 
CD14+ cell gated population was obtained to quantify TLR expression (total of 20,000 
cells acquired for each sample). Isotype control GMFI was used to correct values for 
non-specific binding. Additional gates were then used to identify the CD14++CD16-, 
CD14+CD16++ and CD14++CD16+ monocyte populations and their co-expression with 
TLR2 and TLR4. The expression of TLR2 and TLR4 on all CD14+ monocytes was also 
analysed. 
7.2.4. Statistical Analysis 
Student’s t-test was used to compare before and after training samples in all data. 
Variables that were not normally distributed (CD14+ and CD14++CD16- TLR4 
expression after training, CD14+ and CD14++CD16- TLR2 expression before training 
and CD14+CD16++ TLR2 expression) were also analysed using the Wilcoxon signed 
rank test. The results of the non-parametric test showed similar results to t-tests, and so 
only t-test values will be presented in the results section. Pearson correlation was used 
to assess relationship between VO2peak, BMI waist-to-hip ratio and TLR expression. 
Statistical significance was accepted at P < 0.05. All results are presented as mean ± 
SD. 
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7.3. Results 
7.3.1. Physiological Characteristics 
Participants performed the main high-intensity intermittent training at ~84% of their 
VO2peak both before and after the 2-week training programme. VO2peak was increased by 
7.6% (P = 0.05, Table 7.1). Percentage of heart rate during exercise was 5% lower after 
the training programme (P = 0.001). 
Table 7.1 - Participants characteristics before and after the 2-week training programme 
 Before training After training 
Body Mass (kg) 90.0 ± 7.5 89.9 ± 7.6 
Height (m) 1.77 ± 0.05 1.77 ± 0.05 
BMI (kg·m-2) 28.9 ± 3.2 28.9 ± 3.3 
Waist circumference (cm) 96.3 ± 8.4 95.0 ± 8.8 
Hip circumference (cm) 109.4 ± 5.3 108.2 ± 5.8 
Waist-to-hip ratio 0.88 ± 0.05 0.88 ± 0.05 
VO2peak (l.min-1) 3.40 ± 0.6 3.66 ± 0.5* 
Mean ± SD, BMI: Body Mass Index; * Statistical 
difference found compared with after (P < 0.05) 
7.3.2. Biochemical Analysis 
Blood Cell Count 
Participants presented lower red blood cell count and haemoglobin concentration post-
training compared with pre-training (P < 0.05), but all other variables were unchanged 
(Table 7.2). 
 
 
 
 
92 
 
Table 7.2 – Total blood cell count before and after two weeks of training 
 Before trainig After training 
RBC 4.9 ± 0.7 4.3 ± 0.7* 
HCT (%) 42.6 ± 5.6 37.4 ± 7.1 
HB (g/dL) 15.8 ± 0.9 15.1 ± 1.0* 
WBC (x109/L) 5.7 ± 1.4 6.0 ± 2.0 
NEU (x109/L) 2.6 ± 0.8 3.2 ± 1.2 
LYM (x109/L) 2.2 ± 0.6 2.1 ± 0.7 
MON (x109/L) 0.6 ± 0.2 0.6 ± 0.2 
EOS (x109/L) 0.2 ± 0.1 0.2 ± 0.1 
BAS (x109/L) 0.0 ± 0.1 0.1 ± 0.1 
(RBC = Red blood cells; HCT = Haematocrit; HB = 
Haemoglobin; WBC = white blood cell; NEU = neutrophil; 
LYM = Lymphocyte; MON = Monocyte; EUS = 
Eosinophil; BAS = Basophil); N= 11. * Statistical 
difference compared with after (P < 0.05) 
Monocyte Subpopulation Determination 
No significant difference was found in the proportions of the monocyte subpopulations 
after the exercise training programme (P > 0.05), as seen in Table 7.3. 
Table 7.3 - Monocyte subpopulation before and after two weeks of training programme 
 Before training After training 
CD14++CD16- (%) 77.0 ± 7.8 74.0 ± 9.2 
CD14++CD16+ (%) 4.8 ± 1.8 5.3 ± 2.1 
CD14+CD16++ (%) 3.9 ± 2.9 4.9 ± 2.5 
Non-gated Monocytes (%) 14.3 ± 7.8 14.8 ± 7.5 
No statistical differences (P > 0.05) 
Monocyte TLR Expression Results 
TLR4 expression on CD14 total , CD14++/CD16-, CD14++/CD16+ and CD14+/CD16++ 
monocyte populations are shown in Figure 7.1. TLR4 expression was two-fold higher 
after training on total CD14+ monocytes (t(10)= -2.90, P = 0.02), 2.6-fold higher on 
CD14++ /CD16- (t(10)= -3.05, P = 0.01) and 1.5-fold higher on CD14+ /CD16++ (t(10)= 
-2.40, P = 0.04). There was no significant difference in TLR2 expression before and 
after the training programme (P = 0.21 to 0.48). The GMFI for TLR2 is presented in 
Table 7.4. 
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Figure 7.1- TLR4 expression in monocytes before and after the training programme.  
* Significantly different from pre training (P = 0.05). 
 
Table 7.4 - TLR2 expression in monocytes before and after the training programme 
 CD14 Total CD14++CD16- CD14++CD16+ CD14+CD16++ 
Pre training (GMFI) 24.7 ± 5.8 14.6 ± 7.2 75.5 ± 30.2 39.7 ± 23.4 
Post training (GMFI) 22.4 ± 3.8 16.3 ± 6.7 70.5 ± 24.3 36.9 ± 19.9 
There was no significant correlation between TLR expression and VO2peak, BMI and 
waist-to-hip ratio (all P > 0.05). 
7.4. Discussion 
The aim of this study was to analyse the influence of two weeks of high-intensity 
intermittent exercise training on CD14+ monocyte TLR4 expression in a sedentary, high 
BMI population. In addition, as a secondary purpose, this study examined the influence 
of exercise on classical and pro-inflammatory monocytes and the effect of the 2-week 
exercise training period on TLR4 expression in these monocyte subsets. The novel 
finding from the present study was that six sessions of high-intensity intermittent 
exercise increased total monocyte TLR4 expression with no changes in the monocyte 
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subset population percentages. This increase in TLR4 expression was also seen in all 
monocyte subsets apart from CD14++CD16+. In contrast, TLR2 expression was 
unchanged following exercise training in all monocytes subsets. 
To the author’s knowledge, this was the first study to analyse the influence of a short 
period of high-intensity intermittent exercise training on TLR4 expression in a young, 
high BMI sedentary population. Several previous studies have examined the influence 
of a combination of resistance and aerobic training on monocyte TLR4 expression 
(Coen et al. 2010, Flynn et al. 2003, McFarlin et al. 2006, Stewart et al. 2005, 
Timmerman et al. 2008), but the majority of the studies were conducted on elderly 
women (Coen et al. 2010, Flynn et al. 2003, McFarlin et al. 2006, Timmerman et al. 
2008). In contrast to the findings of the present study, Timmerman et al. (2008) found 
no difference in TLR4 expression on inflammatory monocytes, classical monocytes or 
total monocytes after 12 weeks of training in sedentary elderly females (N=15). 
However, they showed a 64% reduction in the circulating inflammatory monocyte 
numbers after 12 weeks of training. Reasons for such a difference in the findings may 
be attributed to differences in sex, age and physical activity status of the participants 
between studies. Another reason for differences between the present study and other 
training studies cited previously was that the exercise protocol, including the intensity 
and type of exercise, was different, although the total duration of the each session was 
approximately the same (~ 50 min). 
In the present study training did not significantly change total body weight, BMI and 
waist-to-hip circumference. It can therefore be suggested that the changes observed in 
the monocyte TLR4 expression may occur irrespective of BMI. So far, no studies have 
been performed on TLR4 expression in young high BMI sedentary males and so no 
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direct comparisons can be made. However, changes in TLR4 expression (either 
increases or decreases) have been shown to be independent of BMI values in other 
training studies (Stewart et al. 2005, Timmerman et al. 2008). 
Although the high-intensity exercise training protocol increased VO2peak by 7.6%, the 
increase in the monocyte TLR4 expression that occurred may not be a positive outcome 
for a sedentary population. High TLR4 expression may be linked to low-grade chronic 
inflammation, which is linked to the occurrence of diseases. Booth et al. (2010) 
reported increased monocyte TLR4 expression immediately and 1 h after both male and 
female well-trained participants performed a 60 km indoor cycling time trial; however, 
no follow up was performed to see if these values were higher a few hours after the 
exercise. In contrast, it has been observed that monocyte TLR4 expression falls but then 
returns to baseline levels 4 h after long duration exercise (Chapter 5, now published as 
Oliveira and Gleeson 2010). Therefore, the changes in the monocyte TLR4 expression 
seen after a single bout of exercise may not reflect similar findings as a training study. 
The results found in the present study showed an increased TLR4 expression compared 
with the beginning of the training programme even though the blood sample was taken 
48 hours after the end of the last exercise training session. 
Nevertheless, acute inflammatory responses may be one of the stimuli that provoke 
training adaptations in exercised muscle, and people who exercise more have lower 
circulating levels of inflammatory markers (Nicklas and Brinkley 2009). These support 
the idea that exercise has anti-inflammatory effects. The rationale for this may be due to 
the cross-tolerance or desensitisation that physical training may exert on some immune 
cells such as monocytes (Flynn and McFarlin 2006). Even though the present study 
showed an increase in the total monocyte CD14+ TLR4 expression and in the majority 
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of the monocyte subset TLR4 expression, this may be a transitory effect until 
homeostasis reoccurs in the system. These results may be because participants were not 
used to any kind of physical exercise, and were even less used to high-intensity efforts. 
Nevertheless, it is worth noting that the high-intensity training protocol resulted in no 
difference in plasma IL-6 and TNF-α concentration (data presented elsewhere). Similar 
findings to this were reported by McFarlin et al. (2004) after an acute bout of resistance 
exercise performed by trained elderly women. Smart et al. (2011) meta-analysed the 
effects of different training protocols on IL-6 and TNF- α in heart failure patients. They 
found that although exercise training increases VO2peak by around 8% this is not 
correlated to the reduced levels of TNF- α caused by exercise. In addition, IL-6 was 
unchanged. It can be speculated that even with high TLR4 expression after two weeks 
of training, other factors may help to reduce, or at least avoid, the increase of cytokine 
production in a sedentary population. Factors such as changes in the TLR4 pathway 
activation through augmented endogenous ligands in the blood (e.g. plasma IL-1ra, heat 
shock proteins) may contribute to that. To support and prove this idea, a control group 
and analysis of various cytokine production rates would be necessary. It is important to 
note that depending on the ligand, TLR4 expression elicits different responses, which 
will influence the type, magnitude and duration of the inflammatory response. For 
example, the TLR4/MyD88 signalling pathway is used to induce the expression of pro-
inflammatory cytokines, while TLR2/MyD88 stimulates the production of Th2 cells 
(Brown et al. 2010). If TLR4 links with TRAM, TRIF and subsequently associates with 
TRAF3, this pathway will result in the production of IFN-β (which is involved in the 
innate immune response activation) and the production of the anti-inflammatory 
cytokine IL-10 (Brown et al. 2010, ). Once again, direct comparisons with other studies 
are difficult to make when studies examining the effects of high-intensity exercise 
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training programmes on TLR4 pathway or cytokine production have not yet been 
published. 
To conclude, two weeks of high-intensity intermittent exercise training increased total 
CD14+ monocyte TLR4 expression in a sedentary, high BMI population. There was no 
influence of training on the proportions of classical and pro-inflammatory monocyte 
subsets, but TLR4 expression in the majority of these monocyte subsets was higher 
after the six training sessions. It is not certain that the effects seen in this study were due 
to the very short (2 weeks) duration of the training; therefore, a considerably longer 
duration study with the addition of cytokine production analysis may help to establish if 
the elevation on monocyte TLR4 expression is only a transitory effect, and help to 
obtain clearer results on this topic.  
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8. Effects of a 4-week Period of High-intensity Interval Training (HIIT) on 
Monocyte TLR4 Expression in Low Activity Level Participants. 
Abstract: Although there is agreement on the importance of physical exercise for 
general health benefits, the minimal optimal amount needed to improve health status 
and to reduce TLR4 expression (and possible chronic inflammation) is still uncertain. 
The aim of the present study was to analyse the effects of 4-weeks of HIIT on monocyte 
TLR4 expression, classical and pro-inflammatory monocytes, and cytokine production. 
In addition, this study analysed the effects of an acute bout of high-intensity exercise on 
monocyte TLR4 expression immediately and 1 h post-exercise before and after the 
training period. 8 participants (24 ± 9 years old, 26 ± 5 BMI, 2.8 ± 1.0 VO2peak) 
completed 4-weeks of HIIT sessions (three sessions per week). Blood samples were 
taken at three time points (PRE, POST and 1H POST) at the beginning and at the end of 
the training period for analysis of haematocrit, haemoglobin, total white blood cell 
(leukocyte), monocyte counts, monocyte CD14+ TLR4 expression and monocyte 
subsets. 4 participants were selected as a control group (25 ± 3 years old, 24 ± 2 BMI, 
2.91 ± 0.7 VO2peak) and had their blood samples taken at the same time points, but 
without exercise. 4 weeks of training augmented monocyte TLR4 expression in all 
monocyte subsets at immediately post and 1 h post-exercise, but not at rest. Training 
also reduced the percentage of CD14+CD16+ pro-inflammatory monocyte after 4 weeks 
of training, while classical monocytes CD14+CD16- were increased after training. In 
addition, acute exercise reduced total monocyte TLR4 expression 1 h after exercise, but 
this change was not found after 4 weeks of training. Control group showed no changes 
of any variable analysed at any time point. Plasma IL-6 was not different for both 
groups. This may be a transitory effect until homeostasis reoccurs in the system, since 
participants were not used to the level and duration of the exercise prescribed. 
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8.1. Introduction 
As seen in Chapter 5, a single bout of 1.5 h of cycling exercise at 75% of VO2peak 
reduced CD14+ monocyte TLR4 expression immediately and 1 h post-exercise, even 
though there was an increase in the blood monocyte count after exercise. Similarly, a 
study by Lancaster et al. (2005) reported that TLR4 expression on CD14+ blood 
monocytes was reduced following 1.5 h of cycling at 65% VO2max in the heat. Simpson 
et al. (2009) also showed that TLR4 expression on CD14+ blood monocytes was 
reduced after running for 45 min at 75% of VO2max. In contrast, Booth et al. (2010) 
reported increased monocyte TLR4 expression immediately and 1 h after both well-
trained male and female participants performed a 60 km indoor cycling time trial. The 
majority of studies have shown a reduction in monocyte TLR4 expression; however, 
only well-trained participants have been selected to perform moderate intensity, 
continuous exercise protocols. The reduction of TLR4 expression might result in an 
‘open window’ to infections such as URTI in a physically active population, but not 
much is known about the effects of exercise on monocyte TLR4 expression after high-
intensity exercise training in a relatively sedentary population. 
IL-6 and TNF-α are examples of inflammation biomarkers that have been found to be 
related to risk of developing chronic metabolic and cardiovascular diseases. It has been 
suggested that exercise training reduces inflammatory biomarkers (Stewart et al. 2005) 
through exercise-induced reduction of TLR expression and shifts in monocyte 
phenotype (Coen et al. 2010, Flynn et al. 2003, McFarlin et al. 2006, Stewart et al. 
2005, Timmerman et al. 2008). Stewart et al. (2009) and Timmerman et al. (2008) 
demonstrated that 12 weeks of combined aerobic and resistance exercise (3 times per 
week) significantly reduces TLR4 expression in both old and young people. Moreover, 
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studies have shown that HIIT (high power output for a few minutes followed by a rest 
period) results in the augmentation of aerobic capacity and fat oxidation even when 
total exercise time does not exceed 30 min per session (Cornish et al. 2011, Gibala et al. 
2006, Gibala and McGlee 2008, Serpiello et al. 2011, Talanian et al. 2007). These 
findings suggest that high-intensity intermittent exercise is a time-efficient, powerful 
training strategy to stimulate adaptations in the skeletal muscle and improve health in 
both trained and untrained individuals when compared with long-duration, moderate-
intensity aerobic exercise (Gibala et al. 2006, Serpiello et al. 2011, Talanian et al. 
2007). As HIIT lasting up to one hour has been shown to result in greater physiological 
adaptations than moderate exercise of the same duration, it would be interesting to 
know if a high-intensity training protocol can elicit more beneficial immunological 
changes.  
Chapter 7 showed that two weeks of HIIT increased monocyte TLR4 expression in a 
sedentary, high BMI population, however; it is not certain if the effects were due to the 
very short duration of the training and so potentially representing a transitory adaptation 
of the immune system. Therefore, the aim of the present study was to analyse the 
effects of 4-weeks of HIIT on monocyte TLR4 expression, with the addition of cytokine 
production analysis. It was hypothesised that 4 weeks of HIIT would reduce monocyte 
TLR4 expression, especially in the pro-inflammatory monocytes, in a sedentary/low-
activity level population. In addition, this study analysed the effects of an acute bout of 
high-intensity exercise on monocyte TLR4 expression immediately and 1 h post-
exercise before and after the training period, with the hypothesis that acute exercise 
would reduce monocyte TLR4 expression after exercise, but no changes would occur 
after a 4 week training period. 
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8.2.  Methods 
A detailed description of the methods is provided in Chapter 3. Any methods used 
specifically in this study are fully described in this section, while the methods 
previously described are briefly summarised. This Chapter describes the influence of 4 
weeks of high-intensity intermittent exercise training on IL-6 and monocyte TLR4 
expression in a sedentary/low activity level population. In addition, it covers the 
influence of exercise on classical and pro-inflammatory monocytes and the TLR4 
expression before and after the training period in all monocyte subsets. A control study 
was conducted in parallel with the exercise study in order to check for any changes 
during 4 weeks of unchanged (low) activity level in the variables analysed, and will 
also be presented here. This study also analysed the effects of an acute bout of high-
intensity exercise on monocyte TLR4 expression immediately and 1 h post-exercise, 
both before and after the training period. 
8.2.1. Participants 
A total of 12 participants (8 on the exercise group, 4 on the control group) completed 
the study. Participants were recruited through word-of-mouth, e-mails and 
advertisements around the Loughborough University area. They were all non-smokers, 
were not taking any medication and had remained free of symptoms of respiratory 
infection for at least 4 weeks prior to participation in the study. The same 
recommendations and exclusion criteria applied to the resting control group. Potential 
participants read and signed an informed consent form and completed a health screen 
questionnaire as described in Chapter 3.  
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A physical activity questionnaire (IPAQ short version, see appendices) and a VO2peak 
test (described below) were used to determine physical activity levels. To be included in 
either the exercise or control group, participants had to report exercising no more than 3 
hours per week and had a VO2peak less than 45 ml.kg-1.min-1 for men and 40 ml.kg-
1
.min-1 for women. The control participants were asked to maintain and record their 
habitual activity level throughout the 4-week study by filling a short version of the 
IPAQ questionnaire. Participants were asked not exercise for more than 3 hours per 
week outside the training programme while participating in the study. IPAQ results 
showed that 50% of participants did not exercise vigorously during the 4-week period, 
while the rest exercised once (25%) or twice (25%) per week for no more than one 
hour. On average, participants exercised vigorously (8 METs.min-1) or moderately (4 
METs.min-1) for only 9 minutes per day (range 0 – 14 min), and spent no more than 2.9 
(MET)-h per day doing physical activity including walking (3.3 METs.min-1, range 0.6 
– 5.0 METs).  
8.2.2. Experimental Procedures  
Figure 8.1 shows the study design, which included two VO2peak tests, a Familiarisation 
trial, two main trials and a 4-week training period. The control group performed two 
VO2peak tests and two main control trials, as described below: 
 
Figure 8.1 – Study Schema (a) Exercise group; (b) Control group 
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VO2peak Determination  
Participants were asked to abstain from alcohol, caffeine and heavy exercise for at least 
1 day prior to their visit. Participants completed a continuous incremental exercise test 
to volitional exhaustion, as described in Chapter 3, using an electrically braked cycle 
ergometer (Lode Excalibur, Holland). For male participants the test started at 95 W 
with 35 W increments, while for the female participants, the test started at 75 W with 25 
W increments every 3 min until volitional exhaustion. Gas measurements, as well as 
heart rate and RPE values were recorded throughout the test.  
Familiarisation  
Participants returned to the lab approximately 1 week after the VO2peak test. They were 
asked to refrain from any intense physical activity for 24 h prior to the trial. On the day 
of the test, they were required to complete a daily health questionnaire (see appendices) 
to ensure they did not present any cold or flu-like symptoms and that they were in good 
health to participate in the exercise session. They were also asked to fast for at least 10 
h and to refrain from caffeine (and food containing caffeine) for 12 h prior to the visit. 
The Familiarisation test consisted of five 4-min cycling intervals separated by a 2-min 
rest at a load corresponding to that which elicited 90% of participants’ VO2peak. Water 
was consumed ad libitum during exercise. To confirm that participants were exercising 
at the right intensity, a 60-s sample of expired gas was collected at the last minute of the 
second and fourth stages, and measured as described previously. Heart rate and RPE 
measurements were made 30 s from the end of each 4-min stage. The purpose of this 
Familiarisation trial was threefold: first, to habituate the participants to the physical 
stress of the exercise and to the methods involved in the trial; second, to ensure that the 
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participants were able to maintain the selected intensity for 4 min; and third, to ensure 
that the selected work rate actually did elicit a relative intensity of 90% VO2peak. 
Main Trial  
Participants arrived in the laboratory at 08:00 after an overnight fast. They had their 
body mass, hip and waist circumference measured and then remained seated for 5 min. 
A blood sample was then taken, after which, participants performed ten 4-min cycling 
intervals separated by a 2-min rest at a load corresponding to that which elicited 90% of 
participant’s VO2peak. Water was consumed ad libitum during exercise. A 60-s sample 
of expired gas was collected at the last minute of the third, sixth and ninth stages and 
measured as described previously, to confirm that participants were exercising at the 
right intensity. Heart rate and RPE measurements were made 30 s from the end of each 
4-min stage. Body mass was measured again after exercise. Further venous blood 
samples were taken immediately post-exercise and at 1 h after exercise. All participants 
remained seated after exercise until the 1 h post-exercise blood sample had been taken. 
This session was repeated after the end of the 4-week training period. Ambient 
temperature was 21 ± 1 and 22 ± 2ºC, barometric pressure was 757 ± 6 and 758 ± 14 
mmHg and relative humidity was 40 ± 14 and 46 ± 8% before and after 4 weeks of 
training respectively. 
 
Figure 8.2- Example of exercise schema 
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Main Trial – Control Group 
All participants in the control group visited the lab after an overnight fast. They arrived 
at the laboratory at 08:00. After 10 min seated rest, a resting blood sample was taken as 
described in Chapter 3. Participants remained seated for 2 h, and further blood samples 
were taken after 1 h (equivalent to the post-exercise sample in the exercise protocol) 
and 2 h (equivalent to the 1 h post-exercise sample in the exercise protocol). 
Anthropometric measurements were also performed (body mass, hip and waist 
circumference). This same session was repeated after 4 weeks. 
Training Protocol 
Participants completed 12 training sessions over a 4-week period (3 sessions per week – 
mean 11 ± 1 sessions – range 10 – 13). Sessions occurred at any time of the day 
according to participants’ availability. The sessions consisted of the same protocol as 
described in the main trial, yet they had not fasted and did not have a blood sample 
taken. The work rate was adjusted (increased by 5 W for females and 10 W for males) 
during training sessions if participants reported lower RPE and had a lower heart rate 
value when compared with the values achieved in either the main trial or previous 
sessions. Since the training sessions proved to increase participants’ work load, the last 
training session before the repetition of their main trial consisted of a new VO2peak test, 
where a new work load for the post-training main trial was calculated so that the 
relative intensity of the exercise (%VO2peak) was kept constant. 
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8.2.3. Biochemical Analysis 
Blood Analysis  
Haematocrit, haemoglobin, total white blood cell (leukocyte) and monocyte counts 
were determined from the K3EDTA blood at each time point during the main trial 
(PRE, 0, 1 h post-exercise and the equivalent for PRE, 0 and 1 h post at the resting 
group) using an automated haematology analyser and then centrifuged for 10 min at 
1500 g at 4ºC. Aliquots of plasma were immediately stored in a -80 °C freezer for 
future analysis of IL-6. Changes in plasma volume were calculated from measurements 
of haemoglobin and haematocrit according to the method described by Dill and Costill 
(1974). 
Monocyte Subpopulation Determination and TLR Expression  
The same method described in Chapter 7 was also used to analyse the TLR4 expression 
in this study. In brief, samples were analysed on a flow cytometer equipped with the 
CellQuest software package. Cells were gated according to side scatter and CD14-FITC 
expression (which characterises monocytes), and the geometric mean fluorescence 
intensity (GMFI) of the Isotype control (ISO), and of TLR2 and TLR4 antibodies in the 
CD14+ cell gated population was obtained to quantify TLR expression (total of 20,000 
cells acquired for each sample). Isotype control GMFI was used to correct values for 
non-specific binding. Additional gates were then used to identify the CD14++ /CD16-, 
CD14++/CD16+ and CD14+/CD16++ monocyte populations and their expression of both 
TLR2 and TLR4.  
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Enzyme Linked Immunosorbent Assay (ELISA) IL-6 
For the IL-6 analysis plates were coated with anti-human IL-6 monoclonal capture 
antibody (OptEIA, BD Biosciences, Oxford, UK) diluted 1:250 in 0.1 M sodium 
carbonate, then sealed and incubated overnight at 4ºC. After that each plate was washed 
and then blocked with 5% bovine serum albumin (BSA; Probumin, Millipore, Illinois, 
USA) in Trisbuffered saline (TBS). Following this, plates were incubated for 1 h at 
room temperature and then washed. 100 µl of samples or standards were added to the 
wells and incubated at room temperature for 20 h. Standard IL-6 concentrations varied 
from 0.780 to 200 pg·ml-1. Plates were then washed and 100 µl IL-6 detection antibody 
(OptEIA, BD Biosciences, Oxford, UK) diluted 1:250 in TBS-Tween 20 (TBS-T) with 
1% BSA was added per well. Plates were incubated for further 2 h before washing. The 
enzyme streptavidin alkaline phosphatase was diluted 1:2,000 in TBS with 1% BSA 
and 100 µl was added per well. Plates were then incubated for 1 h. After washing, an 
ELISA amplification system was used (substrate + amplifier, Invitrogen, Paisley, UK). 
The reaction was stopped with 50 µl of 10% sulphuric acid stop solution, and the 
absorbance of the wells was read at 490 nm. Samples were analyzed in duplicate with 
an inter-assay coefficient of 7.1%. The cytokine concentration of each sample was 
acquired from the standard curve.  
8.2.4. Statistical Analysis 
Normality tests were carried out on all the data. Data that were not normally distributed 
were analysed using Friedman’s ANOVA. When a statistically significant difference 
was found, a Wilcoxon signed-rank test (corrected for the time points) was carried out 
to locate the difference. Pearson’s correlation was used to analyse whether there was a 
correlation between IL-6 and TLR4 expression. Parametric tests were used for normally 
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distributed data (e.g. t-test, ANOVA). Statistical significance was accepted at P < 0.05. 
All results are presented as mean ± SD. 
8.3. Results 
8.3.1. Physiological Characteristics 
Participants performed their high-intensity intermittent training at ~84% of their 
VO2peak throughout the 4-week training programme. VO2peak was increased by 8.4% (P 
= 0.04, Table 8.1), and maximum work rate during VO2peak test was 10.8% higher after 
the training programme compared with pre training (P = 0.004). No changes were 
found in any other variable measured. 
Table 8.1 – Participants’ anthropometrical and physiological characteristics before and 
after the 4-week training or resting programme 
                                                      Exercise group (N=8)                 Control group (N=4) 
 Before training After training Before 4 weeks After 4 weeks 
Age (Years) 24 ±9 24 ± 9 25 ± 3 25 ± 3 
Body Mass (kg) 79.3 ± 20.7 79.0 ± 20.0 71.3 ± 14.8 71.1 ± 15.0 
Height (m) 1.7 ± 0.1 1.7 ± 0.1 1.7 ± 0.1 1.7 ± 0.1 
BMI (kg·m-2) 26 ± 5 26 ± 4 24 ± 2 24 ± 2 
Waist circumference (cm) 94.1 ± 10.0 91.7 ± 11.8 88.3 ± 5.8 89.6 ± 5.5** 
Hip circumference (cm) 105.0 ± 9.0 103.8 ± 7.8 103.4 ± 5.7 102.4 ± 7.2 
Waist-to-hip ratio 0.90 ± 0.05 0.88 ± 0.06 0.85 ± 0.01 0.88 ± 0.01 
VO2peak (l.min-1) 2.8 ± 1.0 3.1 ± 1.2* 2.9 ± 0.7 2.7 ± 0.4 
Work rate at VO2peak (W) 204 ± 72 226 ± 78* 226 ± 34 235 ± 54 
% VO2peak during exercise 85 ± 4 83 ± 3 -- -- 
* Statistically significant compared with pre training values; ** statistically 
significant compared with pre 4 weeks values. P = 0.05 
8.3.2. Biochemical Analysis 
Monocyte Subpopulation  
The percentage of classical monocytes (CD14++CD16-) was increased at rest after 4 
weeks of training (P = 0.03). On the other hand, the percentage of one of the pro-
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inflammatory monocyte subsets (CD14++CD16+) was reduced after the training period 
(P = 0.02). 
Table 8.2 - Monocyte subpopulation before and after training programme 
 Exercise group Control group 
 Before training After training Before training After training 
CD14++CD16- (%) 82.2 ±7.8 88.6 ± 5.1* 79.5 ± 5.5 82.9 ± 2.7 
CD14++CD16+ (%) 4.6 ± 2.9 3.1 ± 1.6* 4.3 ± 1.1 4.6 ± 1.4 
CD14+CD16++ (%) 3.9 ± 3.3 2.6 ± 2.9 4.9 ± 1.3 3.9 ± 1.0 
Non-gated (%) 9.3 ± 5.0  5.7 ± 2.1 11.3 ± 5.3 8.6 ± 3.1 
* Significant different from pre-training values 
Monocytes were also analysed at post and 1 h post the HIIT was performed (acute 
exercise). Both before and after 4 weeks training trials showed no difference in 
monocyte subset at any time point (P > 0.05). In addition, no difference was found in 
the control group (P > 0.05).  
Monocyte TLR Expression  
As can be seen in Figure 8.3, one acute bout of high-intensity exercise reduced total 
CD14+ monocyte TLR4 expression 1 h post exercise (P = 0.02, Figure 8.3a). However, 
no difference was found for TLR4 expression in any monocyte subset 4 weeks after 
training for the same acute exercise. In contrast, TLR4 expression after 4 weeks of 
training was higher at post and 1 h post exercise when compared with before training in 
all monocyte subsets (Figure 8.3b, P = 0.01).  
 Figure 8.3 – (A) Monocyte TLR4 expression pre, post and 
(B) 
* Different from Pre. 
The control group showed no statistical differences i
blood samples were taken at the same time points as 
nor after 4 weeks (P > 0.05
Table 8.3 - Monocyte TLR4 expression 
GMFI 
 0 h 
Total CD14+ 45 ± 28
CD14+CD16-  38 ± 28
CD14+CD16+  64 ± 43
CD14-CD16++  59 ± 35
No statistical difference at any time point (
As Chapter 4 showed a statistical difference in the TLR4 expression between sex, the 
training group was divided in
acute bout of exercise and of training 
analysed. The male group presented a lower TLR4 expression 
CD14+CD16- (P = 0.03) 
the female group, but this difference w
and females together, total monocyte TLR4 expression
show a difference across time
1 h post exercise before and
after 4 weeks of high-intensity training.  
┼
 Different from before training at the same time point
n monocyte TLR4 expression when 
the exercise group, neither before 
). Values for the control group can be seen 
at 0, 1 h and 2h resting before and after 4 
weeks for the control group 
Before After 
+ 1 h + 2 h 0 h + 1 h
 44 ± 27 49 ± 19 66 ± 26 62 ± 19
 37 ± 28 43 ± 20 63 ± 26 59 ± 18
 61 ± 39 92 ± 63 124 ± 74 119 
 59 ± 32 73 ± 27 95 ± 26 105 
P > 0.05)
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female TLR4 expression was compared individually. Results showed that sex did not 
account for the reduction seen in the total TLR4 expression 1 h post exercise before 
training (P = 0.10).  
Plasma IL-6 
Plasma IL-6 was analysed in duplicate at rest and immediately post-exercise before and 
after 4 weeks of training or resting (for the control group). One participant on the 
exercise group and two participants on the control group showed very high plasma IL-6 
levels compared to the other participants. Both the training and control group showed 
no difference in plasma IL-6 response across time before or after 4 weeks (P = 0.34 and 
P = 0.14 respectively, Table 8.4). No correlation was found between plasma IL-6 and 
TLR4 expression in any monocyte subsets (P > 0.05) in any group. 
Table 8.4 - Plasma IL-6 concentration before and after 4-weeks of training or rest 
(pg/ml) Before training After training 
Exercise 30 ± 59 21 ± 11 
Control 26 ± 26 23 ± 24 
8.4. Discussion 
The aim of the present study was to analyse the effects of 4 weeks of HIIT on monocyte 
TLR4 expression, with the addition of IL-6 analysis. Results found in this study failed 
to support the hypothesis that 4 weeks of HIIT would reduce monocyte TLR4 
expression in a sedentary/low activity population. In fact, 4 weeks of training 
augmented monocyte TLR4 expression in all monocyte subsets at immediately post and 
1 h post-exercise, but not at rest. In addition, this study analysed the effects of an acute 
bout of high-intensity exercise on monocyte TLR4 expression post and 1 h post 
exercise before and after training. Acute exercise reduced total monocyte TLR4 
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expression 1 h after exercise, but this change was not found after 4 weeks of training, 
supporting the study’s alternative hypothesis. The control group showed no difference 
in any of the variables analysed at any time points. 
In relation to the monocyte subsets, classical monocytes (CD14++CD16-) numbers 
increased at resting after 4 weeks of training, and pro-inflammatory monocyte subsets 
(CD14++CD16+) were reduced after the 4-week training period, with no changes seen in 
the control group. Plasma IL-6 results were similar to resting values after the acute 
exercise, before and after 4 weeks in both the training and control group. No correlation 
between TLR4 expression and IL-6 was found at any time points in either group. 
Chapter 7 is thought to be the first study to analyse the influence of a short period of 
high-intensity interval exercise training on TLR4 expression in a young, high BMI, 
sedentary population. The present Chapter was designed to fill this gap in the field and 
to answer some questions that arose in Chapter 7. Several previous studies have 
examined the influence of a combination of resistance and aerobic training on monocyte 
TLR4 expression (Coen et al. 2010, Flynn et al. 2003, McFarlin et al. 2006, Stewart et 
al. 2005, Timmerman et al. 2008), but the majority of the studies were conducted on 
elderly women (Coen et al. 2010, Flynn et al. 2003, McFarlin et al. 2006, Timmerman 
et al. 2008). In contrast to the findings of Chapter 7 and the present study, Timmerman 
et al. (2008) found no difference in TLR4 expression on inflammatory monocytes, 
classical monocytes or total monocytes after 12 weeks of training in sedentary elderly 
females (N=15). However, participants showed a 64% reduction in the inflammatory 
monocyte levels after 12 weeks of training. Similarly, the present study showed a 22% 
reduction in the CD14+CD16+ pro-inflammatory monocyte after 4 weeks of training. In 
addition, classical monocyte CD14+CD16- showed an 8% increase after training. 
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Although some findings are similar to Timmerman et al. (2010) study, reasons for 
differences in the findings can be attributed to differences in sex, age and the physical 
activity status of the participants. Another reason for differences between the present 
study and other training studies cited previously was that the exercise protocol, 
including the intensity and type of exercise was not identical, although the total duration 
of the each session was approximately the same (~ 50 min). 
In the present study, training did not change total body mass, BMI and wait-to-hip 
circumference. It can therefore be suggested that the changes observed in the monocyte 
TLR4 expression may occur irrespective of BMI or waist-to-hip ratio. So far, no studies 
have observed TLR4 expression in young high sedentary males and so no direct 
comparison on this topic can be made. Likewise, changes in TLR4 expression have 
been shown to be independent of physiological characteristics (e.g. BMI, waist-to-hip 
ratio) in other training studies (Stewart et al. 2005, Timmerman et al. 2008). 
The high-intensity exercise training protocol resulted in positive physiological 
outcomes including an increase in VO2peak by 8.4%, and a 10.8% elevation on the 
maximum work rate during the second VO2peak test compared with the first test. 
However, the increase in the monocyte TLR4 expression that occurred after the training 
may or may not be a positive outcome for a sedentary population. High IL-6 values and 
augmented TLR4 expression may be linked to low-grade chronic inflammation, which 
is linked to the occurrence of diseases (Nicklas and Brinkley 2009). Even though the 
present study showed an increase in the classical monocyte CD14+CD16-, and in the 
TLR4 expression in all monocyte subsets after an acute bout of exercise, the high-
intensity training protocol resulted in no difference in plasma IL-6 results. Smart et al. 
(2011) meta-analysed the effects of different training protocols on IL-6 and TNF- α in 
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heart failure patients. It was found that although exercise training increases VO2peak by 
around 8%, this is not correlated to the reduced levels of TNF- α caused by exercise. In 
addition, IL-6 was unchanged. It can be speculated that even with high TLR4 
expression after two weeks of training other factors may help to reduce, or at least 
avoid, the increase of cytokine production in a sedentary population. In addition, 
augmented classical monocytes TLR4 expression may be related to the increase in pro-
inflammatory cytokines, which would contribute to the immunity-enhanced protection 
induced by exercise. Factors such as changes in the TLR4 pathway activation through 
augmented endogenous ligands in the blood (e.g. heat shock proteins, TRAF6 pathway 
activation) may contribute to that. It is important to note that depending on the ligand, 
TLR4 expression elicits different responses, which will influence the type, magnitude 
and duration of the inflammatory response. To conclude, 4 weeks of high-intensity 
intermittent exercise training increased monocyte TLR4 expression in all monocyte 
subsets at post and 1 h post an acute bout of exercise, but not at rest in a young 
sedentary population. Training also reduced the percentage of CD14+CD16+ pro-
inflammatory monocyte after 4 weeks of training, while classical monocyte 
CD14+CD16- was increased after training. This may be a transitory effect until 
homeostasis reoccurs in the system, since participants were not used to the level and 
duration of the exercise prescribed. However more studies in the area are required. 
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8.  
9. General Discussion 
This Chapter contains a summary of the main results of the studies comprised within 
this thesis, followed by a broad discussion that ties the studies together and discusses 
the relevance of these findings and the practical implications within the field of Sports 
Sciences and Exercise Immunology. In addition, the limitations of the studies within 
this thesis are outlined, together with the importance and recommended direction of 
future studies. 
The general aim of this thesis was twofold: 1) to investigate the effect of different 
exercise protocols on TLR2 and TLR4 expression and 2) to investigate if resting 
immunological markers were different according to sex and physical activity level. The 
main findings of the studies comprised within this thesis were: 
- The blood measurements and the coefficient of variation of the flow cytometry 
and cell count analysis were highly reproducible and had a low coefficient of 
variation.  
- Monocyte TLR4 expression was higher in females compared with males during 
rest.  
- Monocyte TLR4 expression was higher in the population with a low compared 
with a high level of physical activity, although the level of physical activity did 
not relate to URTI incidence.  
- Plasma levels of cytokine were not significantly different neither between 
groups with different levels of physical activity (after stimulation) nor after 4 
weeks of training. 
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- Prolonged cycling exercise at 75% VO2peak reduced monocyte TLR4 expression 
in healthy men, with values returning to normal after 4h. 
- Monocyte CD14+ TLR4 expression did not significantly change after two 
VO2peak tests separated by 2 hours. 
- Two weeks of high-intensity training had no influence on the proportions of 
classical and pro-inflammatory monocyte subsets. 
- TLR4 expression in the majority of the monocyte subsets (apart from 
CD14++CD16+) was higher after six training sessions in high BMI sedentary 
men. 
- 4 weeks of training augmented monocyte TLR4 expression in all monocyte 
subsets at immediately post and 1 h post-exercise compared to pre training 
values, but changes were not seen at rest. 
- 4 weeks of HIIT reduced the percentage of CD14+CD16+ pro-inflammatory 
monocytes.  
- 4 weeks of HIIT increased the percentage of CD14+CD16- classical monocytes. 
- Acute exercise reduced total monocyte TLR4 expression 1 h after exercise in 
low physical activity level participants, but this change was not found after 4 
weeks of training. 
The results of this thesis suggest that TLR4 expression is different in accordance to sex 
and physical activity level. As seen in Chapter 4, females have a higher TLR4 
expression compared with males. It has been suggested that hormones per se (e.g. 
cortisol and oestrogen) may influence the immune system (Gillum et al. 2011), but the 
changes in the immune system seen after exercise seem to not be influenced by 
hormonal changes (Lancaster et al. 2005, Gillum et al. 2011). Moreover, some studies 
found that the menstrual cycle did not affect some immunological parameters in trained 
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athletes (Burrows et al. 2002). One of the limitations of Chapter 4 was that the phase of 
the menstrual cycle was not determined when the blood sample was taken and it was 
not established whether or not the females were taking oral contraceptives. 
Nevertheless, as suggested by Gillum et al. (2011) and Burrows et al. (2002), sex 
differences in immune function among athletes can be taken in consideration 
independently of females’ menstrual phase, and this may also apply when analysing 
TLR4 expression. However, both male and female levels of TLR4 expression were not 
related to cytokine production or URTI incidence, and therefore this difference perhaps 
was not enough to considerably affect susceptibility to URTI. It would, nevertheless, be 
recommended that males and females are allocated in separate groups when analysing 
TLR4 expression, or caution is taken when interpreting future data from mixed gender 
studies. 
When participants were divided by their physical activity status, CD14+ monocyte 
TLR4 expression was higher in the LOW group compared to the HIGH group. These 
data are in accordance to McFarlin et al. (2004, 2006) and Stewart et al. (2005), where 
sedentary populations of both sexes presented higher CD14+ monocyte TLR4 
expression compared with more active individuals. This may be an indication of why 
low levels of physical activity are related to chronic inflammation and the development 
of some diseases (Stewart et al. 2005). However, Chapter 4 in this thesis did not 
examine the cytokine production and URTI episodes in the LOW group, but instead 
compared the MED and HIGH groups in relation to URTI and cytokine production. 
There were found to be no significant differences in the number of URTI episodes 
between MED and HIGH groups, but the HIGH group produced higher levels of the 
anti-inflammatory cytokine IL-10 following antibody stimulation. It has been suggested 
that IL-10 is able to impair the ability of APCs to promote the differentiation and 
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proliferation of CD4+ T cells, thereby regulating both initiation and perpetuation of 
adaptive T-cell responses (Murphy et al. 2008).  
Further results from this thesis showed that different types of acute exercise result in 
different responses in the TLR expression. The findings from Chapter 5 is in agreement 
with Lancaster et al. (2005) showing that strenuous, long duration physical activity 
reduces TLR4 expression by around 40% immediately post and 1 h post exercise, 
despite the increase in blood monocyte numbers. This is also in accordance with 
Simpson et al. (2009), who reported changes in TLR4 but no changes in TLR2 
expression after 45 minutes of running as 75% VO2max. These findings were supported 
in this thesis by the fact that the control participants showed no change in their TLR4 
expression at the same time points.  
Factors such HLA.DR, HSPs, cortisol, internalisation of the TLR receptors, and the 
circulating concentration of cytokines such as IL-6 have been suggested to be 
responsible for the changes in TLR expression (Gleeson et al. 2006, Simpson et al. 
2009). The decline in TLR4 expression may influence and be influenced by the changes 
in the accessory signal molecule expression HLA.DR, as seen by Simpson et al. (2009). 
HLA.DR is a transmembrane MHC II that activates Th cells and activates the acquired 
immune system. However, the changes found by Simpson et al. (2009) in both TLR4 
and HLA.DR were suggested to be due to a reduction in the total number of classical 
monocytes in the circulation. Classical monocytes are the major monocyte subset 
responsible for activating anti-inflammatory cytokine production, which would 
therefore help in the prevention of a pathogen invasion. Thus, the reduction seen in 
TLR4 expression after a single bout of acute exercise (as seen Chapter 5 but not in 
Chapter 6) may lead to a briefly impaired immune function and an increased 
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susceptibility to infection such as URTI, since TLR4 values returned to resting levels 
after 4 hours. This thesis did not measure cortisol response after exercise; however, the 
possibility of cortisol influencing TLR expression was discarded since Lancaster et al. 
(2005) showed that changes in TLR expression were independent of large diurnal 
changes in cortisol. 
Some endogenous ligands such as HSPs and cytokines may act as inhibitors of TLR 
expression (Gleeson et al. 2006, Simpson et al. 2009). It is well established that 
circulating IL-6 levels are elevated after a single bout of exercise, and it has been 
suggested that IL-6 plays an important role in down regulating TLR expression in 
different conditions (Lancaster et al. 2005). Pedersen and Febbraio (2008) showed that 
intramuscular IL-6 production and release into the circulation increase during prolonged 
exercise. As TLR activation also results in the production of IL-6 through the NF-kB 
signalling pathway, it is hypothesised that high levels of IL-6 in the blood after exercise 
down regulate the expression of TLRs. The decline in TLR expression is associated 
with reductions in accessory signal molecule expression (e.g. CD80 and CD86) and 
antigen-presenting cell activation after acute exercise. Furthermore, HSPs are proteins 
present in all cells and are up-regulated during physiological stress and it has been 
suggested that, in a similar manner to LPS, HSPs act as activators of TLR4. Kilmartin 
and Reen (2004) showed that repeated monocyte exposure to HSP60 (as seen by 
athletes’ constant training) induces a tolerance to HSP and a ‘cross-tolerance’ to LPS 
stimulation, subsequently reducing TLR4 activation.  
All potential factors mentioned above (HLA.DR, HSPs, and IL-6) could potentially 
increase the risk of URTI due to reduction in TLR4 expression; however, it could also 
support the idea of a controlled immune system working against unnecessary 
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inflammation, avoiding the development of chronic inflammation and preventing the 
progression to chronic diseases. This can be seen as a negative feedback and, repeated 
exposure to similar conditions may result in a ‘training’ adaptation of the immune 
system, where by an inhibition of extra pro-inflammatory cytokine production occurs, 
helping the body to not overreact towards changes in the body homeostasis caused by 
exercise. This, again, can be a way for the immune system to avoid chronic 
inflammatory responses. However, this may also augment the chances that the immune 
system may not be able to react as effectively against common infection such as URTI 
(Lancaster et al. 2005; Gleeson et al. 2006). Caution in interpreting these findings might 
be taken since Booth et al. (2010) found that soluble serum factors taken from blood 
sampled after exercise does not change resting monocyte TLR expression in vitro, 
suggesting that changes in TLR expression found after exercise are not caused by 
endogenous ligands. One of the factors that has not been discussed in depth in the 
literature to date is the possible internalisation or shedding of the TLR receptors after 
exercise, and clearly more research in this area is needed. 
Despite the majority of literature showing findings to suggest a reduction in TLR 
expression after exercise, the results in this thesis showed that two VO2peak tests 
separated by two hours did not influence TLR4 expression in healthy men, suggesting 
that a prolonged and more intense exercise may be necessary to instigate a response in 
this aspect of the immune system. The same suggestion would be valid for TLR2 
expression, since strenuous exercise in Chapter 5 did not instigate statistically 
significant changes in this receptor, providing the reason why TLR2 was not analysed 
in further Chapters. Differences in participants’ fitness levels, exercise type, duration, 
intensity and methods used to analyse the variables may contribute to the different 
results found. Booth et al. (2010) showed an increase in TLR2 and TLR4 expression 
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after a 60 km cycling time trial (mean completion time 92 ± 7 min, heart rate 83 ± 5% 
bpm) in both male and female participants. Interestingly, Chapter 8 showed that 10 
repetitions of 4 min of intense exercise reduced total CD14+ monocyte TLR4 
expression 1 h post exercise in sedentary participants, but this change was not seen 
when the same test was performed after 4 weeks of training. This result suggests some 
adaptation in the immune system to the stress provoked by exercise training in a 
population that were not previously accustomed to high-intensity of exercise.  
Both Chapters 7 and 8 analysed the effects of a period of HIIT on monocyte subset 
populations and on TLR4 expression in these monocyte subsets in a sedentary or low 
level of physical activity population. Based on results reported by Timmerman et al. 
(2008), it was hypothesised that pro-inflammatory monocytes numbers would reduce 
after training, together with the TLR4 expression. However, as seen in Chapter 7, 
although there were no changes in monocyte subsets numbers, TLR4 expression was 
augmented after 2 weeks of HIIT sessions. In addition, in Chapter 8 it was 
demonstrated that there was an increase in the numbers of classical monocytes, and a 
reduction in the pro-inflammatory monocyte subset (CD14++CD16+) after the 4-week 
training period, with no changes seen in the control group. Moreover, TLR4 expression 
did not change at rest after 4 weeks of training. These results suggest that a transitory 
increase in the TLR4 expression occurs after 2 weeks due to possible training-induced 
stress and adaptations, but these changes are not seen after a 4-week protocol. 
Nevertheless, it is important to mention that participants’ aerobic capacity and work 
load increased considerably in a short period in both groups. 
It was interesting to note that after 4 weeks of training a reduction of pro-inflammatory 
monocyte numbers together with an increase of classical monocytes was observed. As 
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pro-inflammatory monocytes express more TLR4 compared with classical monocytes 
(Ziegler-Heitbrock 2007), reduction in the numbers of the former type of monocyte 
may contribute to the reduction of chronic inflammation, while an increase in the 
classical monocytes may help the prevention of diseases by augmenting the production 
of anti-inflammatory cytokines. However, more investigation in this area is required 
since plasma IL-6 results were similar to resting values after the training period in both 
the training and control group, and no correlation between monocyte TLR4 expression 
and plasma IL-6 concentration was found at any time point in either group. One 
possible explanation for this surprising finding could be related to the experimental 
protocol used. While Timmerman et al. (2008) used a combination of 20 min of 
endurance exercise (at 60-70% of heart rate reserve) and some resistive exercise in 
elderly woman, the studies in Chapters 7 and 8 used healthy young male participants, 
and a protocol that could be considered very intense (10 x 4 min at ~90% VO2peak with 2 
min resting for 1 hour) compared to other studies (McFarlin et al. 2004, Lancaster et al. 
2005, Stewart et al. 2005, Timmerman et al. 2008, Simpson et al. 2009).  
It is therefore concluded that: 
- Resting TLR4 expression is different according to sex and physical activity 
level. It is recommended that males and females are considered separately when 
analysing some immunological markers such as TLR4 expression.  
- Acute bouts of prolonged strenuous exercise reduce TLR4 expression for a few 
hours after the completion of the exercise, thus extra caution should be taken in 
this time period to ensure athletes minimise the risk of contracting an infection, 
especially commonly infections encountered in our daily lives such as URTI. 
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- Short duration exhaustive exercise separated by 2 hours does not change TLR4 
expression. 
- High-intensity intermittent training improves participants’ aerobic capacity and 
modifies monocyte subpopulation concentrations in the blood. Further research 
is suggested in this area to better understand the changes in TLR4 expression 
and monocyte subsets after different training protocols. 
Although this thesis examined the effects of exercise on TLR2 and TLR4 expression, it 
is important to note that the immune system is an inter-communicable system and that 
the clinical significance of small singular changes requires further investigation (Walsh 
et al. 2011). It is therefore acknowledged that several extra analyses could have been 
done to try to elucidate the effects of exercise on immune function. However this was 
not possible due to time and money constrains, and was beyond the agreed scope of this 
thesis. 
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Example of informed consent form 
INFORMED CONSENT FORM 
(to be completed after Participant Information Sheet has been read) 
The purpose and details of this study have been explained to me. I understand that this study is designed 
to further scientific knowledge and that all procedures have been approved by the Loughborough 
University Ethical Advisory Committee. 
 
I have read and understood the information sheet and this consent form. 
I have had an opportunity to ask questions about my participation. 
I understand that I am under no obligation to take part in the study. 
I understand that I have the right to withdraw from this study at any stage for any reason, and that I will 
not be required to explain my reasons for withdrawing. 
I understand that all the information I provide will be treated in strict confidence and will be kept 
anonymous and confidential to the researchers unless (under the statutory obligations of the agencies 
which the researchers are working with), it is judged that confidentiality will have to be breached for the 
safety of the participant or others.  
 
I agree to participate in this study. 
 
Your name 
 
Telephone contact 
 
E-mail:  
 
 Your signature 
 
Signature of investigator 
 
Date 
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Example of Health Screen questionnaire 
HEALTH SCREEN QUESTIONNAIRE FOR STUDY VOLUNTEERS Name/Number   
...............……. 
As a volunteer participating in a research study, it is important that you are currently in good health and 
have had no significant medical problems in the past.  This is (i) to ensure your own continuing well-
being and (ii) to avoid the possibility of individual health issues confounding study outcomes. 
If you have a blood-borne virus, or think that you may have one, please do not take part in this research 
[include for projects involving invasive procedures]. 
Please complete this brief questionnaire to confirm your fitness to participate: 
1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise  Yes  No  
(b) attending your general practitioner  Yes  No  
(c) on a hospital waiting list  Yes  No  
2. In the past two years, have you had any illness which required you to: 
(a) consult your GP  Yes  No  
(b) attend a hospital outpatient department  Yes  No  
(c) be admitted to hospital   Yes  No  
3. Have you ever had any of the following: 
(a) Convulsions/epilepsy   Yes  No  
(b) Asthma   Yes  No  
(c) Eczema   Yes  No  
(d) Diabetes   Yes  No  
(e) A blood disorder   Yes  No  
(f) Head injury   Yes  No  
(g) Digestive problems   Yes  No  
(h) Heart problems   Yes  No  
(i) Problems with bones or joints      Yes  No  
(j) Disturbance of balance/coordination   Yes  No  
(k) Numbness in hands or feet   Yes  No  
(l) Disturbance of vision   Yes  No  
(m) Ear / hearing problems   Yes  No  
(n) Thyroid problems   Yes  No  
(o) Kidney or liver problems   Yes  No  
(p) Allergy to nuts   Yes  No  
4. Has any, otherwise healthy, member of your family under the 
age of 35 died suddenly during or soon after exercise?   Yes  No  
If YES to any question, please describe briefly if you wish (eg to confirm problem was/is short-lived, 
insignificant or well controlled.)  
.........................................................................................................................................................................
....................................................................................................................... 
5 Additional questions for female participants 
(a) are your periods normal/regular?   Yes  No  
(b) are you on “the pill”?   Yes  No  
(c) could you be pregnant?     Yes  No  
(d) are you taking hormone replacement therapy (HRT)? Yes  No  
In case of emergency, please provide details of your next of kin. 
Name:  ………………………………Telephone Number:………………………………….. 
Are you currently involved in any other research studies at the University? 
 Yes  No  
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Example of a daily Health screen questionnaire 
 
Health Questionnaire 
 
Please complete the following brief questions to confirm your fitness to participate in today’s session: 
1) At present do you have any health problems for which you are: 
a) On medication, prescribed or otherwise    YES         NO        .  
b) Attending your general practitioner     YES         NO        .  
2) Do you have any symptoms of ill health, such as those associated with a cold or other common 
infection?  
YES         NO        . 
3) Are you presently acting as a subject for any other experiment or research study?  
YES         NO        . 
If you have answered yes to any of the above questions please give more details below: 
____________________________________________________________________________________ 
Do you want to take part in today’s experiments?   YES         NO        . 
 
Signature:                                   Date:                     
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Participant information sheet – resting study 
The effects of habitual level of physical activity on blood markers of inflammation and leukocyte 
TLR expression 
Miss Marta Oliveira, Loughborough University – M.Oliveira@lboro.ac.uk 
Professor Mike Gleeson, Loughborough University – M.Gleeson@lboro.ac.uk 
Participant Information Sheet 
Background 
The health benefits of regular physical exercise have been reported for several years. Moderate to 
vigorous exercise training brings about physiological adaptations that can reduce the risk of chronic 
diseases. In contrast, sedentary behaviour is associated with an increased risk of chronic diseases such as 
coronary heart disease, diabetes, hypertension and rheumatoid arthritis. 
It has been suggested that increased levels of inflammatory markers in the plasma are related to the 
development of some diseases. However, it has been suggested that reduced levels of Toll-like receptor 
(TLR) expression over the long term may be beneficial to health due to associated reductions in chronic 
inflammation, consequently reducing the risk of developing chronic diseases. Several studies have 
attempted to explain the association between ageing and/or sedentary lifestyle and health risks, but no 
solid conclusions about the mechanisms have been found yet, justifying the need for more studies in this 
area. The proposal of this study is to investigate the effects of habitual level of physical activity on blood 
markers of inflammation and leukocyte (white blood cell) TLR expression. 
 
This study is part of a Student research project funded by Loughborough University and it will be 
conducted in the Exercise Immunology Laboratory of the School of Sport, Exercise and Health Sciences. 
All the data will be treated in strict confidence in and will be kept anonymous and confidential to the 
researchers, in accordance with the University regulations for data security, storage and analysis.  
 
Participant requirements 
 
You will be asked to come to the Exercise Immunology Laboratory for one visit where we will explain 
you in details the aim and procedures of the research. You will then be asked to fill in a health 
questionnaire and an informed consent form. After that you will have your body mass and height 
measured and will be asked to give us a venous blood sample (12ml). 
The last thing you will be asked to do is to answer a questionnaire about your physical activity habits. In 
total this will take about 30 minutes. 
A proportion of participants will be randomly selected to come to the lab for an identical second visit, to 
assess the intra-individual variability of the measurements. You can choose not to participate in that if 
you wish. 
 
We will provide you with some results of the blood analysis (e.g. your red and white blood cell counts, 
haemoglobin concentration)  at the end of the whole study if you wish. If you change your mind after 
taking part, you can withdraw from this study at any time, for any reason and you will not be asked to 
explain your reasons for withdrawing. Please just contact the main investigator. 
 
If you have any more questions related to this study please contact: 
Marta Oliveira (M.Oliveira@lboro.ac.uk – 01509 226371 / 07813195537) 
 
If you are not happy with how the research was conducted the University has a policy relating to 
Research Misconduct and Whistle Blowing which is available online at 
http://www.lboro.ac.uk/admin/committees/ethical/Whistleblowing(2).htm.  
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Participant information sheet – Acute study 
Study Title: Effects of acute exercise on Toll-like receptor expression on human monocytes 
Location:  Exercise physiology teaching laboratory and Exercise Immunology Laboratory, 
Loughborough University 
Investigators: Marta Oliveira 
Supervisor:  Professor Mike Gleeson 
 
Background: Several studies have indicated that physical activity may play a role in modifying 
inflammatory and immune responses. Furthermore, it has been suggested that a large number of immune 
system aspects can be influenced by strenuous and/or chronic exercise, which may impair immune 
function and increases susceptibility to infection such as upper respiratory tract infections. 
Although the number of studies which analyse the immune response after exercise has increased, the 
mechanisms which modulate it are not fully understood, and more studies examining the clinical 
importance of changes and function  in the immune system are required.  
Toll-like receptors (TLRs) are receptors located in the immune cell surfaces (e.g. monocytes) responsible 
for recognizing pathogens. TLRs expression may change after exercise, which may influence the changes 
in the immune function. Therefore, the intention of this research is to investigate the effects of 1.5-h of 
exercise at 75% of the VO2max on the monocyte TLR2 and 4 expression.  
Volunteers: Physically active males (18 - 35 yr) 
Study Procedures: You will be required to attend the lab on 3 occasions in total. 
During your first visit you will undertake a maximal oxygen uptake (VO2max ) test in a cycle ergometer. 
The total duration of the visit is around 1 hour (~30 min for the test). 
On your second visit baseline measurements (weight and height) will be recorded. You will also perform 
a Familiarisation, which consist in 1.5-h cycling at 75% VO2max. Basically, this session is for you to get 
used to the protocol that is going to be used in the main trial. This visit will take around 2 hours in total. 
On the third visit we will ask you to come to the lab 2-h after having a normal breakfast, and we will 
weigh you. A blood sample (7ml) will be taken before exercise. As soon as possible after that you will be 
cycling for 1.5-h at 75% of your VO2max. Four more blood samples will be required: One immediately 
after cycling, one 1 hour after, one 4 hours after exercising and the last one 24-h after finishing the trial 
(total of 35 ml of blood during the whole trial, using repeated veinpuncture). 200ml of water will be 
given every 20 min of exercise. Expired air samples will be obtained every 30min using the Douglas 
bags. Heart Rate and RPE will be collected every 20 min throughout the trial. Body mass measurement 
will be repeated after the trial. 
Requirements: You will be asked to refrain from caffeine and any strenuous exercise 24h before coming 
to the laboratory and the following 24 hours after the end of the trial. A food diary will be given to be 
filled the day before and the 24 hours after the last blood sample.  
Possible risk and discomforts: The risks involved in this study are minimal. Prior to the study you will 
complete a University Health Questionnaire to assess your suitability for the study. Each session will be 
attended by suitable qualified personnel. 
Benefits of the study: From the measurements made we will be able to give you information regarding 
your aerobic fitness and will be able to give you some indication of your immune response to exercise. 
Data protection: All samples will be used to examine Toll-like receptor response and will be disposed of 
immediately after analysis. All information obtained in this study will be kept confidential, however, we 
will be pleased to discuss the results with you at a later date if you wish. 
 
Further Questions please contact any of the following: 
Marta Oliveira E-mail: M.Oliveira@lboro.ac.uk Tel: 01509 22 6371  
Professor Mike Gleeson  E-mail: M.Gleeson@lboro.ac.uk  Tel: 01509 22 6345 
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Participant Information Sheet – Exercise training study (4-week) 
 
Effects of acute exercise and a period of exercise training on Toll-like receptor expression on 
human monocytes 
 
Investigators: Professor Mike Gleeson – M.Gleeson@lboro.ac.uk 
  Miss Marta Oliveira – M.Oliveira@lboro.ac.uk 
  Mr Kurt Rumley – K.Rumley-09@student.lboro.ac.uk 
 
Background 
Toll-Like Receptors (TLRs) are recognition receptors located on the surface of immune cells (such as 
monocytes and neutrophils), responsible for recognizing pathogens. TLRs play an important role in the 
activation of both the innate and the acquired immune system. 
Several studies have indicated that physical activity may play a role in modifying inflammatory and 
immune responses. Furthermore, it has been suggested that a large number of immune system aspects can 
be influenced by strenuous and/or chronic exercise, including the TLR expression on monocytes. This 
may reduce inflammation markers and may prevent the development of some diseases such as diabetes 
and rheumathoid arthritis. 
The mechanisms which modulate TLR expression after exercise are not fully understood, and more 
studies examining the clinical importance of changes in TLR expression and function on the generation 
of immune responses are required. Therefore, the intention of this research is to determine the effects of 
an acute bout of aerobic exercise and a short period of exercise training on monocyte TLR expression in 
the general population. 
 
Study procedures 
You will be asked to come to the lab at the following times: 
Visit 1 –Introductory visit: one of the researchers will explain the aim and procedures of the research for 
you. You will also fill in a health questionnaire, a physical activity questionnaire and an informed consent 
form at this visit. In addition, you will then be allocated to a training or control treatment for 4 weeks. 
 
Visit 2 - You will be asked to perform an incremental cycling to volitional exhaustion (VO2max test). At 
this visit you will also have their body weight, height and waist and hip circumference measured. 
 
Visit 3 - Familiarisation trial for exercise group: If you are allocated to this group you will be asked to 
arrive in the lab at around 8.30am. During the familiarisation you will complete five 4-minute intervals at 
a workload corresponding to approximately 85%-90% of you VO2max separated by 2-min rest. Heart 
rate and rating of perceived exertion will be monitored throughout the trial. 
 
Visit 4 (a) - First main trial exercise group: you will arrive at the lab at 7.30am after an overnight fast. 
After resting for 5-10 min, you will have your blood taken. You will then complete ten 4-min bouts of 
cycle ergometer exercise at 90% of their VO2max separated by 2-min rest. On cessation of exercise 
another blood sample will be taken. You will then be asked to remain seated for one more hour, and a 
final blood sample will be taken. A light meal will be given upon completion of this trial. 
 
Visit 4 (b) - Main trial for control group: If you are allocated to the control group you will be asked to 
come to the lab at 7.30am after an overnight fast. After resting for 5-10 min, you will have your blood 
taken. You will then be asked to remain seated for two more hours, and blood samples will be taken after 
1 hour and 2 hours. A light meal will be given upon completion of the trial. 
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Training sessions: for the training sessions you will be asked to complete the training session mentioned 
on visit 4a (without the blood sampling) 3 times per week for 4 weeks. Participants allocated to the 
control group will be asked not to exercise for a 4-week period (i.e. continue with their normal routine). 
 
Visit 5 - Last main trial after the 4 weeks of training or control: You will be asked to repeat the same 
procedures as on visit 4a or 4b. 
 
The blood samples will be analysed for total blood cell count (e.g. Red blood cells, Haemoglobin 
concentration, White blood cell count), and for immunological aspects such as monocyte TLRs 
expression. All will be done immediately after the last blood collection has been taken each day. In 
addition, some plasma samples will be stored for future analyses, which will be done as soon as the study 
is finished. All the remaining samples would be appropriately disposed according to the Departmental 
H&S guidelines. 
 
Possible risk and discomforts 
The risks involved in this study are minimal. Prior to the study you will have completed a University 
Health Questionnaire to assess your suitability for the study. 
Physical challenge (the VO2max test and the exercise protocol) - The VO2max test requires you to 
exercise to volitional fatigue. The discomfort is, therefore, by definition tolerable and when it becomes 
intolerable you will simply stop exercising. The exercise protocol is considered as high-intensity exercise 
however the discomfort is tolerable as well. If you cannot continue any further you will simply stop 
exercising. The risks of injury for both procedures are minimal, as it is a well-controlled procedure with 
the investigator standing alongside you throughout the test to ensure your safety at all times. 
Blood sampling – taking blood via the vein puncture may cause minor bruising, but good practice 
minimizes the risk.  
All this information will be kept confidential; however, we will be pleased to discuss the results with you 
at a later date. 
 
Benefits of participating 
At the end of the study you will be given a fitness result, and from the measurements made we will be 
able to give you information regarding your resting blood status i.e. red and white blood cell numbers and 
haemoglobin concentration if you wish. 
 
Additional information 
You can withdraw from the study at any time, for any reason and you will not be asked to explain your 
reasons for withdrawing. 
If you are not happy with the way the research is conducted, please visit the University policy relating to 
Research Misconduct and Whistle Blowing which is available online at 
http://www.lboro.ac.uk/admin/committees/ethical/Whistleblowing(2).htm.  
If you have any more questions or would you like to discuss the project a bit further, please contact one 
of the investigators: 
Professor Mike Gleeson - email: m.gleeson@lboro.ac.uk Tel: 01509 226345 
Miss Marta Oliveira - PhD student in the SSES, email: M.Oliveira@lboro.ac.uk tel: 01509 226371, 
(mobile): 07813195537 
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Participant Information Sheet Probiotic 1 
 
Study Title: Effects of a probiotic (Lactobacillus salivarius) intervention on infection, cold 
symptom duration/severity and mucosal immunity in endurance athletes 
 
Investigator:   Professor Michael Gleeson 
Background 
Your immune system protects your body against infections. It is now widely accepted that single bouts of 
prolonged strenuous exercise are associated with a temporary depression of immune function.  This is 
said to provide a ‘window of opportunity’ for infections to enter the body.  It is thought that these effects 
may be cumulative over a period of time, so that during periods of heavy training and competition, 
athletes’ immune systems may become chronically depressed, i.e. demonstrating lower values in 
measures of immune function integrity at rest.  In this study we intend to examine the efficacy of a 
probiotic supplement containing “friendly” bacteria (Lactobacillus salivarius strain) on infection 
incidence and resting immune function in sportsmen and women over a 4-month period.  
 
Study Procedures 
You will complete health-history questionnaires concerning your past and present health status and this 
will be followed by a small (5 mL) blood sample being taken to check that your red and white cell counts 
are normal. These will be used to confirm that you are suitable subject for the study. You will be 
randomly allocated to the supplement group or a placebo group and be required to take one sachet 
containing 2 grams of powder (which you add to a cup of water) with your breakfast every day for 4 
months. You will be provided with the sachets which should be kept unopened in your fridge until the 
day of use. For the duration of the study you should not consume any other fermented milk products (i.e. 
other probiotics, yoghurts, soured milk or cream, crème fraiche). 
 
You will be required to provide a resting blood sample (no more than 20 mL) and a saliva sample at the 
start of the study, after 2 months of taking the product and again after 4 months of taking the product 
(which is the end of the study) for assessment of your immune status. On these occasions you will need to 
arrive at the Exercise Immunology Laboratory after an overnight fast (though you are free to drink water 
at any time). At weekly intervals during the study you are requested to complete 3 short questionnaires to 
evaluate your current mood state, physical activity levels, and record any symptoms of colds/flu or 
digestive discomfort that you may have experienced in the past week.  
 
Measurements 
Height and weight will be determined in normal clothing. 
A resting saliva sample will be taken at the start and end of the study. This will be collected by dribbling 
into a plastic tube. 
A blood sample will be taken at the start of the study, after 2 months of taking the product and again after 
4 months of taking the product (which is the end of the study). This will be no more than 20 ml of blood 
(less than 1% of your total blood volume). You are requested to return your used sachets (and any unused 
ones) at the end of the study period and you will be asked few questions about the palatability and ease of 
administration of the powder. 
 
Possible risk and discomforts 
The risks involved in this study are minimal. The supplement has been previously tested in human trials 
without any adverse effects being reported. The supplement was formulated by a company specialising in 
the manufacture of probiotics for human consumption and has been tested to confirm that it is free from 
contamination with an extensive list of banned steroids and stimulants. Should you experience any ill 
effects you are asked to contact the investigators immediately and stop taking the supplement. Prior to the 
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study you will have completed a University Health Questionnaire and a Bowel Disease History 
Questionnaire to assess your suitability for the study. All information regarding the blood and saliva tests 
will be used for immunological purposes and then disposed of immediately. This information will be kept 
confidential; however, we will be pleased to discuss the results with you at a later date. 
 
You are free to withdraw from the study at any time 
 
Benefits of the study 
From the measurements made we will be able to give you information regarding your resting blood status 
i.e. red and white blood cell numbers, haemoglobin concentration and saliva IgA concentration.  
 
Confidentiality 
Personal information will be treated in confidence, and will be stored on a computer, identified by a 
number rather than by your name – in line with the Data Protection Act. 
 
Further questions? 
Please contact any of the following investigators: 
Principal Investigator:  Professor Mike Gleeson email: m.gleeson@lboro.ac.uk 
        Tel: 01509 226345 
Other Investigators:  
Miss Catherine Coyle, BSc final year student in the School of Sport and Exercise Sciences, email: 
C.M.Coyle-08@student.lboro.ac.uk   Tel (mobile): 07730565690 
 
Miss Marta Oliveira MSc; Technician and Exercise Physiology PhD student in the School of Sport and 
Exercise Sciences,      email: M.Oliveira@lboro.ac.uk 
Tel: 01509 226371 Tel (mobile):  07813195537  
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Participant Information Sheet – Probiotic 2 
 
Study Title: Effects of a probiotic (Yakult) intervention on infection, cold symptom 
duration/severity and mucosal immunity in endurance athletes 
Investigator:   Professor Michael Gleeson 
Background 
Your immune system protects your body against infections. It is now widely accepted that single bouts of 
prolonged strenuous exercise are associated with a temporary depression of immune function.  This is 
said to provide a ‘window of opportunity’ for infections to enter the body.  It is thought that these effects 
may be cumulative over a period of time, so that during periods of heavy training and competition, 
athletes’ immune systems may become chronically depressed, i.e. demonstrating lower values in 
measures of immune function integrity at rest.  In this study we intend to examine the efficacy of a 
probiotic supplement (Yakult) containing “friendly” bacteria (Lactobacillus casei Shirota strain) on 
infection incidence and resting immune function in sportsmen and women over a 4-month period.  
 
Study Procedures 
You will complete health-history questionnaires concerning your past and present health status and this 
will be followed by a small (5 mL) blood sample being taken to check that your red and white cell counts 
are normal. These will be used to confirm that you are suitable subject for the study. You will be 
randomly allocated to the supplement group or a placebo group and be required to take two 65 ml bottles 
of the product every day (one to be taken with your breakfast and one with your evening meal) for 4 
months. You will be provided with the bottles which should be kept unopened in your fridge until the day 
of use. These products have a shelf life of 2 weeks, so you will need to come to the laboratory for further 
supplies every 2 weeks. For the duration of the study you should not consume any other fermented milk 
products (i.e. other probiotics, yoghurts, soured milk or cream, crème fraiche). 
 
You will be required to provide a resting blood sample (no more than 20 mL) and a saliva sample at the 
start of the study, after 2 months of taking the product and again after 4 months of taking the product 
(which is the end of the study) for assessment of your immune status. On these occasions you will need to 
arrive at the Exercise Immunology Laboratory after an overnight fast (though you are free to drink water 
at any time). At weekly intervals during the study you are requested to complete 3 short questionnaires to 
evaluate your current mood state, physical activity levels, and record any symptoms of colds/flu or 
gastrointestinal problems that you may have experienced in the past week.  
 
Measurements 
Height and weight will be determined in normal clothing. 
A resting saliva sample will be taken at the start of the study, after 2 months of taking the product and 
again after 4 months of taking the product (which is the end of the study). This will be collected by 
dribbling into a plastic tube. 
A blood sample will be taken at the start of the study, after 2 months of taking the product and again after 
4 months of taking the product (which is the end of the study). This will be no more than 20 ml of blood 
(less than 1% of your total blood volume). You are requested to return your used bottles (and any unused 
ones) when you return to the lab to collect fresh supplies of product every 2 weeks. At the end of the 
study period you will be asked few questions about the palatability and ease of administration of the 
product. 
 
Possible risk and discomforts 
The risks involved in this study are minimal. The product is commercially available as a fermented milk 
drink (sold as a food in all major supermarkets) and has been drunk extensively by humans without 
adverse effects for over 70 years (currently by 25 million people in 31 different countries). The 
supplement was formulated and manufactured by a company specialising in the manufacture of probiotics 
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for human consumption. Some people taking probiotics for the first time may notice a slight change in 
bowel function in the first few days. This does not always happen, and will settle down. Should you 
experience any ill effects you are asked to contact the investigators immediately and stop taking the 
product. Prior to the study you will have completed a University Health Questionnaire and a Bowel 
Disease History Questionnaire to assess your suitability for the study. All information regarding the 
blood and saliva tests will be used for immunological purposes and then disposed of immediately. This 
information will be kept confidential; however, we will be pleased to discuss the results with you at a 
later date. 
 
You are free to withdraw from the study at any time 
 
Benefits of the study 
From the measurements made we will be able to give you information regarding your resting blood status 
i.e. red and white blood cell numbers, haemoglobin concentration and saliva IgA concentration.  
 
Confidentiality 
Personal information will be treated in confidence, and will be stored on a computer, identified by a 
number rather than by your name – in line with the Data Protection Act. 
 
Further questions? 
Please contact any of the following investigators: 
Principal Investigator:  Professor Mike Gleeson email: m.gleeson@lboro.ac.uk 
        Tel: 01509 226345 
Other Investigators:  
Miss Marta Oliveira MSc; Technician and Exercise Physiology PhD student in the School of Sport and 
Exercise Sciences,      email: M.Oliveira@lboro.ac.uk 
Tel: 01509 226371 Tel (mobile):  07813195537 
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Appendix (H) IPAQ questionnaires - long and short versions. 
